Updated on 2021/03/16

写真a

 
ALEKSIC Branko
 
Organization
Graduate School of Medicine International Collaborative Program in Comprehensive Medical Science between Nagoya University and University of Adelaide Designated associate professor
Title
Designated associate professor
Contact information
メールアドレス
External link

Degree 2

  1. PhD ( 2009.3   Nagoya University ) 

  2. MD ( 2001.3   University of Belgrade, School of Medicine ) 

Research Interests 6

  1. cognitive genetics

  2. resequencing

  3. CNV

  4. genetics

  5. Schizophrenia

  6. cognitive genetics

Research Areas 2

  1. Others / Others  / Schizophrenia, genetics, CNV, resequencing, cognitive genetics

  2. Life Science / Neuroscience-general

Research History 4

  1. Nagoya University   Graduate School of Medicine International Collaborative Program in Comprehensive Medical Science between Nagoya University and University of Adelaide   Designated associate professor

    2018.4

      More details

  2. Fujita Health University

    2008.4

      More details

    Country:Japan

  3. Institute of Mental Health

    2003.12 - 2005.3

      More details

    Country:Serbia

  4. Clinical Center of Serbia

    2002.4 - 2003.11

      More details

    Country:Serbia

Education 3

  1. Nagoya University   Graduate School, Division of Medical Sciences   Child and adolescent psychiatry

    2006.4 - 2009.4

      More details

    Country: Japan

  2. Nagoya University   Graduate School of Medicine   Doctoral course (Child psychiatry)

    2005.4 - 2009.3

      More details

  3. Belgrade University   Faculty of Medicine

    1994.10 - 2001.3

Professional Memberships 7

  1. International College of Neuropsychopharmacology

    2012.1

  2. American Psychiatric Association/International Member

    2012.1

  3. World Federation of Societies of Biological Psychiatry

    2011.4

  4. Serbian Medical Society

  5. The International Society of Psychiatric Genetics

  6. Serbian Medical Chamber

  7. Serbian Medical Chamber

      More details

▼display all

Awards 1

  1. International congress presentation award

    2013.4   Japanese Society for Biological Psychiatry  

     More details

    Country:Japan

 

Papers 195

  1. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: The first case-control study in Asia.

    Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N

    Vaccine   ( 30 ) page: 4292-4298   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  2. Total palliative care for a patient with multiple cerebral infarctions that occurred repeatedly in association with gastric cancer (Trousseau's syndrome).

    Ukai K, Okajima A, Yamauchi A, Sasaki E, Yamaguchi Y, Kimura H, Aleksic B, Ozaki N.

    Palliative and Supportive Care   ( 1 ) page: 1-4   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  3. Differential effects of diazepam, tandospirone, and paroxetine on plasma brain-derived neurotrophic factor level under mental stress.

    Tamaji A, Iwamoto K, Kawamura Y, Takahashi M, Ebe K, Kawano N, Kunimoto S Aleksic B, Ozaki N.

    Human Psychopharmacology   Vol. Clinical and Experimental ( 27 ) page: 1-4   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  4. Effectiveness of duloxetine for the treatment of chronic nonorganic orofacial pain.

    Nagashima W, Kimura H, Ito M, Tokura T, Arao M, Aleksic B, Yoshida K, Kurita K, Ozaki N.

    Clin Neuropharmacol   ( 35 ) page: 273-277   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  5. An evaluation of polymorphisms in casein kinase 1 delta and epsilon genes in major psychiatric disorders.

    Matsunaga S, Ikeda M, Kishi T, Fukuo Y, Aleksic B, et al.

    Neurosci Lett   ( 529 ) page: 66-69   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  6. Resequencing and Association Analysis of the KALRN and EPHB1 Genes And Their Contribution to Schizophrenia Susceptibility.

    Kushima I, Nakamura Y, Aleksic B, Ikeda M, Ito Y, et al.

    Schizophrenia Bulletin   ( 38 ) page: 552-560   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  7. Common variants in MAGI2 gene are associated with increased risk for cognitive impairment in schizophrenic patients.

    Koide T, Banno M, Aleksic B, Yamashita S, Kikuchi T, et al.

    PLoS One   ( 7 ) page: e36836   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  8. Evaluation of factors affecting continuous performance test identical pairs version score of schizophrenic patients in a Japanese clinical sample.

    Koide T, Aleksic B, Kikuchi T, Banno M, Kohmura K, et al.

    Schizophr Res Treatment   Vol. 2012   page: 970131   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  9. Effects of sedative antidepressants on prefrontal cortex activity during verbal fluency task in healthy subjects: a near-infrared spectroscopy study.

    Kohmura K, Iwamoto K, Aleksic B, Sasada K, Kawano N, et al.

    Psychopharmacology (Berl)     page: 1-7   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  10. No associations found between the genes situated at 6p22.1, HIST1H2BJ, PRSS16, and PGBD1 in Japanese patients diagnosed with schizophrenia. Reviewed

      Vol. Part B-Neuropsychiatric Genetics ( 159B ) page: 456-464   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  11. Sexual dysfunction and hyperprolactinemia in Japanese schizophrenic patients taking antipsychotics.

    Kikuchi T, Iwamoto K, Sasada K, Aleksic B, Yoshida K, et al.

    Prog Neuropsychopharmacol Biol Psychiatry   ( 37 ) page: 26-32   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  12. Slower adaptation to driving simulator and simulator sickness in older adults.

    Kawano N, Iwamoto K, Ebe K, Aleksic B, Noda A, et al.

    Aging Clin Exp Res   ( 24 ) page: 285-289   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  13. Genetic evidence for association between NOTCH4 and schizophrenia supported by a GWAS follow-up study in a Japanese population.

    Ikeda M, Aleksic B, Yamada K, Iwayama-Shigeno Y, Matsuo K, et al.

    Molecular Psychiatry     page: in press   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  14. The postpartum depressive state in relation to perceived rearing: a prospective cohort study.

    Hayakawa N, Koide T, Okada T, Murase S, Aleksic B, et al.

    PLoS One   ( 7 ) page: e50220   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  15. What is a rational antidepressant treatment for major depression in patients with Parkinson's disease?

    Hagikura M, Iwamoto K, Aleksic B, Ozaki N

    Psychiatry and Clinical Neurosciences   ( 66 ) page: 463-463   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  16. Prospective Study on the Association between Harm Avoidance and Postpartum Depressive State in a Maternal Cohort of Japanese Women.

    Furumura K, Koide T, Okada T, Murase S, Aleksic B, et al.

    PLoS One   ( 7 ) page: e34725   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  17. Wisconsin Card Sorting Test scores and clinical and sociodemographic correlates in Schizophrenia: multiple logistic regression analysis.

    Banno M, Koide T, Aleksic B, Okada T, Kikuchi T, et al.

    BMJ     page: open 2   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  18. Analysis of the VAV3 as Candidate Gene for Schizophrenia: Evidences From Voxel-Based Morphometry and Mutation Screening.

    Aleksic B, Kushima I, Hashimoto R, Ohi K, Ikeda M, et al.

    Schizophrenia Bulletin.     page: in press   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  19. Combination use of Beck Depression Inventory and two-question case-finding instrument as a screening tool for depression in the workplace.

    Adachi Y, Aleksic B, Nobata R, Suzuki T, Yoshida K, et al.

    BMJ     page: open 2   2012

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  20. Present and Future of Research in Mood Disorder.

      ( 16 ) page: 20-25   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  21. 気分障害研究の現状と展望.

    尾崎紀夫, 小出隆義, 中村由嘉子, 國本正子, Aleksic B

    学術の動向   ( 16 ) page: 7-7   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  22. Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population.

    Yoshimura T, Usui H, Takahashi N, Yoshimi A, Saito S, et al.

    Progress in Neuro-Psychopharmacology & Biological Psychiatry   ( 35 ) page: 1268-1272   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  23. Efficacy of donepezil for the treatment of visual and multiple sensory hallucinations in dementia with Lewy bodies.

    Ukai K, Aleksic B, Ishihara R, Shibayama H, Iritani S, et al.

    Clinical Neuropsychopharmacology and Therapeutics   ( 2 ) page: 56-58   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  24. Loss of function studies in mice and genetic association link receptor protein tyrosine phosphatase alpha to schizophrenia.

    Takahashi N, Nielsen KS, Aleksic B, Petersen S, Ikeda M, et al.

    Biol Psychiatry   ( 70 ) page: 626-635   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  25. Depression associated with alcohol intake and younger age in Japanese office workers: a case-control and a cohort study.

    Ogasawara K, Nakamura Y, Aleksic B, Yoshida K, Ando K, et al.

    J Affect Disord   ( 128 ) page: 33-40   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  26. Reliability and validity of a new sexual function questionnaire (Nagoya Sexual Function Questionnaire) for schizophrenic patients taking antipsychotics.

    Kikuchi T, Iwamoto K, Sasada K, Aleksic B, Yoshida K, et al.

    Hum Psychopharmacol   ( 26 ) page: 300-306   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  27. Prospective study of maternal depressive symptomatology among Japanese women.

    Ishikawa N, Goto S, Murase S, Kanai A, Masuda T, Aleksic B et al.

    Journal of Psychosomatic Research   ( 71 ) page: 264-269   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  28. Genome-wide association study of schizophrenia in a Japanese population.

    Ikeda M, Aleksic B, Kinoshita Y, Okochi T, Kawashima K, et al.

    Biol Psychiatry   ( 69 ) page: 472-478   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  29. Necessity for ethical consideration of research in the aftermath of disaster.

    Iijima Y, Aleksic B, Ozaki N

    Psychiatry Clin Neurosci   ( 65 ) page: 535-536   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  30. A case control association study and cognitive function analysis of neuropilin and tolloid-like 1 gene and schizophrenia in the Japanese population.

    Banno M, Koide T, Aleksic B, Yamada K, Kikuchi T, et al.

    PLoS One   ( 6 ) page: e28929   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  31. A survey of antipsychotic polypharmacy in outpatients at Nagoya University Hospital.

    Yoshimi A, Noda Y, Aleksic B, Senzaki K, Ohashi M, et al.

    Clinical Neuropsychopharmacology and Therapeutics   ( 1 ) page: 43-49   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  32. Gene-wide association study between the methylenetetrahydrofolate reductase gene (MTHFR) and schizophrenia in the Japanese population, with an updated meta-analysis on currently available data.

    Yoshimi A, Aleksic B, Kawamura Y, Takahashi N, Yamada S, et al.

    Schizophrenia research   ( 124 ) page: 216-222   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  33. Influence of HTR2A polymorphisms and parental rearing on personality traits in healthy Japanese subjects.

    Nakamura Y, Ito Y, Aleksic B, Kushima I, Yasui-Furukori N, et al.

    J Hum Genet   ( 55 ) page: 838-841   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  34. Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility.

    Kushima I, Nakamura Y, Aleksic B, Ikeda M, Ito Y, et al.

    Schizophrenia Bulletin     page: in press   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  35. Association study of ubiquitin-specific peptidase 46 (USP46) with bipolar disorder and schizophrenia in a Japanese population.

    Kushima I, Aleksic B, Ito Y, Nakamura Y, Nakamura K, et al.

    J Hum Genet   ( 55 ) page: 133-136   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  36. Association study of bromodomain-containing 1 gene with schizophrenia in Japanese population.

    Kushima I, Aleksic B, Ikeda M, Yamanouchi Y, Kinoshita Y, et al.

    Am J Med Genet B Neuropsychiatr Genet   ( 153B ) page: 786-791   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  37. A two-stage case-control association study of the dihydropyrimidinase-like 2 gene (DPYSL2) with schizophrenia in Japanese subjects.

    Koide T, Aleksic B, Ito Y, Usui H, Yoshimi A, et al.

    J Hum Genet   ( 55 ) page: 469-472   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  38. Copy number variation in schizophrenia in the Japanese population.

    Ikeda M, Aleksic B, Kirov G, Kinoshita Y, Yamanouchi Y, et al.

    Biol Psychiatry   ( 67 ) page: 283-286   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  39. Genetic association study of KREMEN1 and DKK1 and schizophrenia in a Japanese population.

    Aleksic B, Kushima I, Ito Y, Nakamura Y, Ujike H, et al.

    Schizophr Res   ( 118 ) page: 113-117   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  40. Comparison of pharmacological profiles of serotonin norepinephrine reuptake inhibitors.

    Adachi Y, Aleksic B, Ozaki N

    Clinical Neuropsychopharmacology and Therapeutics   ( 1 ) page: 10-15   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  41. BDNF is not associated with schizophrenia: Data from a Japanese population study and meta-analysis.

    Kawashima K, Ikeda M, Kishi T, Kitajima T, Yamanouchi Y, et al.

    Schizophrenia research   ( 112 ) page: 72-79   2009

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  42. Dense association mapping of dihydropyrimidinase-like 2 (DPYSL2) gene in susceptibility to schizophrenia in a Japanese population.

    Ito Y, Koide T, Aleksic B, Inada T, Iwata N, et al.

    Neuroscience Research   ( 65 ) page: S253-S253   2009

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  43. Genetic analysis of the gene coding for DARPP-32 (PPP1R1B) in Japanese patients with schizophrenia or bipolar disorder.

    Yoshimi A, Takahashi N, Saito S, Ito Y, Aleksic B, et al.

    Schizophr Res   ( 100 ) page: 334-341   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  44. An association study of tachykinin receptor 3 gene with schizophrenia in the Japanese population.

    Saito S, Takahashi N, Maeno N, Ito Y, Aleksic B, et al.

    NeuroReport   ( 19 ) page: 471-473   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  45. Association study of the calcineurin A gamma subunit gene (PPP3CC) and methamphetamine-use disorder in a Japanese population.

    Kinoshita Y, Ikeda M, Ujike H, Kitajima T, Yamanouchi Y, Aleksic B, Kishi T, Kawashima K, Ohkouchi T, Ozaki N, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Sekine Y, Iyo M, Sora I, Iwata N.

    Ann N Y Acad Sci   ( 1139 ) page: 57-62   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  46. An association between serotonin receptor 3B gene (HTR3B) and treatment-resistant schizophrenia (TRS) in a Japanese population.

    Ji X, Takahashi N, Aleksic B, Ishihara R, Nagai T, et al.

    Nagoya journal of medical science   ( 70 ) page: 2   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  47. A genetic association study of the FXYD domain containing ion transport regulator 6 (FXYD6) gene, encoding phosphohippolin, in susceptibility to schizophrenia in a Japanese population.

    Ito Y, Nakamura Y, Takahashi N, Saito S, Aleksic B, et al.

    Neurosci Lett   ( 438 ) page: 70-75   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  48. Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample.

    Ikeda M, Takahashi N, Saito S, Aleksic B, Watanabe Y, et al.

    Schizophrenia research   ( 101 ) page: 1-8   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  49. No association between the oligodendrocyte-related gene PLP1 and schizophrenia in the Japanese population.

    Aleksic B, Ikeda M, Ishihara R, Saito S, Inada T, et al.

    Journal of Human Genetics   ( 53 ) page: 863-866   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  50. Association of SOX10 with schizophrenia in the Japanese population.

    Maeno N, Takahashi N, Saito S, Ji X, Ishihara R, Aoyama N, Aleksic B, Miura H, Ikeda M, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Iwata N, Inada T, Ozaki N.

    Psychiatr Genet   ( 17 ) page: 227-231   2007

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  51. Association study between the transferrin gene and schizophrenia in the Japanese population.

    Maeno N, Takahashi N, Saito S, Ji X, Aleksic B, et al.

    NeuroReport   ( 18 ) page: 517   2007

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  52. Gap junction coding genes and schizophrenia: a genetic association study.

    Aleksic B, Ishihara R, Takahashi N, Maeno N, Ji X, et al.

    J Hum Genet   ( 52 ) page: 498-501   2007

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  53. Rare genetic variants in the gene encoding histone lysine demethylase 4C (KDM4C) and their contributions to susceptibility to schizophrenia and autism spectrum disorder

    Kato Hidekazu, Kushima Itaru, Mori Daisuke, Yoshimi Akira, Aleksic Branko, Nawa Yoshihiro, Toyama Miho, Furuta Sho, Yu Yanjie, Ishizuka Kanako, Kimura Hiroki, Arioka Yuko, Tsujimura Keita, Morikawa Mako, Okada Takashi, Inada Toshiya, Nakatochi Masahiro, Shinjo Keiko, Kondo Yutaka, Kaibuchi Kozo, Funabiki Yasuko, Kimura Ryo, Suzuki Toshimitsu, Yamakawa Kazuhiro, Ikeda Masashi, Iwata Nakao, Takahashi Tsutomu, Suzuki Michio, Okahisa Yuko, Takaki Manabu, Egawa Jun, Someya Toshiyuki, Ozaki Norio

    TRANSLATIONAL PSYCHIATRY   Vol. 10 ( 1 )   2020.12

     More details

    Publisher:Translational Psychiatry  

    DOI: 10.1038/s41398-020-01107-7

    Web of Science

    Scopus

  54. Functional characterization of rare NRXN1 variants identified in autism spectrum disorders and schizophrenia

    Ishizuka Kanako, Yoshida Tomoyuki, Kawabata Takeshi, Imai Ayako, Mori Hisashi, Kimura Hiroki, Inada Toshiya, Okahisa Yuko, Egawa Jun, Usami Masahide, Kushima Itaru, Morikawa Mako, Okada Takashi, Ikeda Masashi, Branko Aleksic, Mori Daisuke, Someya Toshiyuki, Iwata Nakao, Ozaki Norio

    JOURNAL OF NEURODEVELOPMENTAL DISORDERS   Vol. 12 ( 1 )   2020.9

  55. Publisher Correction: Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder (Nature Neuroscience, (2017), 20, 9, (1217-1224), 10.1038/nn.4598)

    Lim E.T.

    Nature Neuroscience   Vol. 23 ( 9 )   2020.9

     More details

    Publisher:Nature Neuroscience  

    DOI: 10.1038/s41593-020-0681-z

    Scopus

  56. A recurrent PJA1 variant in trigonocephaly and neurodevelopmental disorders. Reviewed International journal

    Toshimitsu Suzuki, Toshifumi Suzuki, Matthieu Raveau, Noriko Miyake, Genki Sudo, Yoshinori Tsurusaki, Takaki Watanabe, Yuki Sugaya, Tetsuya Tatsukawa, Emi Mazaki, Atsushi Shimohata, Itaru Kushima, Branko Aleksic, Tomoko Shiino, Tomoko Toyota, Yoshimi Iwayama, Kentaro Nakaoka, Iori Ohmori, Aya Sasaki, Ken Watanabe, Shinichi Hirose, Sunao Kaneko, Yushi Inoue, Takeo Yoshikawa, Norio Ozaki, Masanobu Kano, Takeyoshi Shimoji, Naomichi Matsumoto, Kazuhiro Yamakawa

    Annals of clinical and translational neurology   Vol. 7 ( 7 ) page: 1117 - 1131   2020.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    OBJECTIVE: Neurodevelopmental disorders (NDDs) often associate with epilepsy or craniofacial malformations. Recent large-scale DNA analyses identified hundreds of candidate genes for NDDs, but a large portion of the cases still remain unexplained. We aimed to identify novel candidate genes for NDDs. METHODS: We performed exome sequencing of 95 patients with NDDs including 51 with trigonocephaly and subsequent targeted sequencing of additional 463 NDD patients, functional analyses of variant in vitro, and evaluations of autism spectrum disorder (ASD)-like phenotypes and seizure-related phenotypes in vivo. RESULTS: We identified de novo truncation variants in nine novel genes; CYP1A1, C14orf119, FLI1, CYB5R4, SEL1L2, RAB11FIP2, ZMYND8, ZNF143, and MSX2. MSX2 variants have been described in patients with cranial malformations, and our present patient with the MSX2 de novo truncation variant showed cranial meningocele and partial epilepsy. MSX2 protein is known to be ubiquitinated by an E3 ubiquitin ligase PJA1, and interestingly we found a PJA1 hemizygous p.Arg376Cys variant recurrently in seven Japanese NDD patients; five with trigonocephaly and one with partial epilepsy, and the variant was absent in 886 Japanese control individuals. Pja1 knock-in mice carrying p.Arg365Cys, which is equivalent to p.Arg376Cys in human, showed a significant decrease in PJA1 protein amount, suggesting a loss-of-function effect of the variant. Pja1 knockout mice displayed moderate deficits in isolation-induced ultrasonic vocalizations and increased seizure susceptibility to pentylenetetrazole. INTERPRETATION: These findings propose novel candidate genes including PJA1 and MSX2 for NDDs associated with craniofacial abnormalities and/or epilepsy.

    DOI: 10.1002/acn3.51093

    Scopus

    PubMed

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/acn3.51093

  57. Generation and analysis of novel Reln-deleted mouse model corresponding to exonic Reln deletion in schizophrenia. Reviewed International journal

    Masahito Sawahata, Daisuke Mori, Yuko Arioka, Hisako Kubo, Itaru Kushima, Kanako Kitagawa, Akira Sobue, Emiko Shishido, Mariko Sekiguchi, Akiko Kodama, Ryosuke Ikeda, Branko Aleksic, Hiroki Kimura, Kanako Ishizuka, Taku Nagai, Kozo Kaibuchi, Toshitaka Nabeshima, Kiyofumi Yamada, Norio Ozaki

    Psychiatry and clinical neurosciences   Vol. 74 ( 5 ) page: 318 - 327   2020.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    AIM: A Japanese individual with schizophrenia harboring a novel exonic deletion in RELN was recently identified by genome-wide copy-number variation analysis. Thus, the present study aimed to generate and analyze a model mouse to clarify whether Reln deficiency is associated with the pathogenesis of schizophrenia. METHODS: A mouse line with a novel RELN exonic deletion (Reln-del) was established using the CRISPR/Cas9 method to elucidate the underlying molecular mechanism. Subsequently, general behavioral tests and histopathological examinations of the model mice were conducted and phenotypic analysis of the cerebellar granule cell migration was performed. RESULTS: The phenotype of homozygous Reln-del mice was similar to that of reeler mice with cerebellar atrophy, dysplasia of the cerebral layers, and abrogated protein levels of cerebral reelin. The expression of reelin in heterozygous Reln-del mice was approximately half of that in wild-type mice. Conversely, behavioral analyses in heterozygous Reln-del mice without cerebellar atrophy or dysplasia showed abnormal social novelty in the three-chamber social interaction test. In vitro reaggregation formation and neuronal migration were severely altered in the cerebellar cultures of homozygous Reln-del mice. CONCLUSION: The present results in novel Reln-del mice modeled after our patient with a novel exonic deletion in RELN are expected to contribute to the development of reelin-based therapies for schizophrenia.

    DOI: 10.1111/pcn.12993

    Scopus

    PubMed

    researchmap

  58. Characterization of a schizophrenia patient with a rare RELN deletion by combining genomic and patient-derived cell analyses. Reviewed International journal

    Yuko Arioka, Akihiro Hirata, Itaru Kushima, Branko Aleksic, Daisuke Mori, Norio Ozaki

    Schizophrenia research   Vol. 216   page: 511 - 515   2020.2

     More details

    Publishing type:Research paper (scientific journal)  

    Genetic studies have identified rare RELN variants as risk factors for psychiatric disorders. However, additional genetic factors appear to be necessary for disease onset. Detailed genetic information and the use of patient-derived neuronal cells may thus enable to discover these disease-related additional factors. Here, we performed whole-genome sequencing of a schizophrenia patient with a rare RELN deletion and his healthy mother, and examined the phenotypes of 3D-cultured neuronal cells derived from induced pluripotent stem cells of this patient. Our results revealed that, along with the RELN deletion, neuronal death was promoted in this patient; thus, neuronal death may be a vulnerable factor for schizophrenia.

    DOI: 10.1016/j.schres.2019.10.038

    Web of Science

    Scopus

    PubMed

    researchmap

  59. Drug-Induced Extrapyramidal Symptoms Scale of the Norwegian version: inter-rater and test-retest reliability. Reviewed International journal

    Bernhard Weidle, Ashmita Chaulagain, Kenneth Stensen, Branko Aleksic, Norbert Skokauskas, Toshiya Inada

    Nordic journal of psychiatry   Vol. 73 ( 8 ) page: 546 - 550   2019.11

     More details

    Publishing type:Research paper (scientific journal)  

    Background: The Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) is a multidimensional rating scale designed for the fast, easy and reliable assessment of extrapyramidal symptoms (EPSs) induced by antipsychotics. Aim: The aim of this study was to validate the level of inter-rater and test-retest reliability of the Norwegian translation of this scale. Methods: A total of 125 video clips showing a variety of or no signs of EPSs were used in the present study. The participants recorded were Japanese psychiatric patients receiving first- and/or second-generation antipsychotics. A total of 103 patients (47 males and 56 females), diagnosed with schizophrenia (n = 68) or mood disorders (n = 35) appeared in the video clips. Their mean age was 48.7 ± 16.3 years (range 18-80) at the time of video recording. Inter-rater agreement was assessed with five raters and test-retest reliability with three. Results: Inter-rater reliability analyses showed interclass correlation coefficients (ICCs) ranging from 0.74 to 0.93 for each individual item. Test-retest reliability analysed independently for each rater ranged from 0.71 to 0.96. Conclusions: Inter-rater and test-retest agreement exhibited satisfactory ICC levels above 0.70. The Norwegian version of the DIEPSS is a reliable instrument for the assessment of drug-induced EPSs.

    DOI: 10.1080/08039488.2019.1665708

    Web of Science

    Scopus

    PubMed

    researchmap

  60. INVESTIGATION OF RARE SINGLE-NUCLEOTIDE DAB1 VARIANTS AND ITS CONTRIBUTION TO SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER SUSCEPTIBILITY Reviewed International journal

    Nawa Yoshihiro, Kimura Hiroki, Ishizuka Kanako, Kushima Iraru, Aleksic Branko, Ozaki Norio

    EUROPEAN NEUROPSYCHOPHARMACOLOGY   Vol. 29   page: S164 - S165   2019.10

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.euroneuro.2019.08.099

    Web of Science

  61. Relation Between Perinatal Depressive Symptoms, Harm Avoidance, and a History of Major Depressive Disorder: A Cohort Study of Pregnant Women in Japan. Reviewed International journal

    Chika Kubota, Toshiya Inada, Tomoko Shiino, Masahiko Ando, Branko Aleksic, Aya Yamauchi, Maya Sato, Masako Ohara, Satomi Murase, Mako Morikawa, Yukako Nakamura, Takashi Okada, Setsuko Goto, Atsuko Kanai, Norio Ozaki

    Frontiers in psychiatry   Vol. 10   page: 515 - 515   2019.7

     More details

    Publishing type:Research paper (scientific journal)  

    Introduction: The relationship between perinatal depressive symptoms, harm avoidance (HA), and a history of major depressive disorder (MDD) was examined in a prospective cohort study. Methods: This study was conducted from May 1, 2011, to December 31, 2016. A history of MDD was evaluated using the Inventory to Diagnose Depression, Lifetime version during pregnancy. Depressive state and HA were evaluated during pregnancy and at 1 month postnatal using the Edinburgh Postnatal Depression Scale (EPDS) and Temperament and Character Inventory, respectively. The relationship between these variances was examined using structural equation modeling. Results: A total of 338 participants with complete data were included in the present study. Pregnant women with compared with those without a history of MDD were observed to have a significantly higher intensity of HA and more severe depressive symptoms in both the prenatal and postnatal periods. A history of MDD affected the severity of depressive symptoms [standardized path coefficient (SPC) = 0.25, p < 0.001] and the intensity of HA during pregnancy (SPC = 0.36, p < 0.001). The intensity of HA during pregnancy affected that at 1 month postnatal (SPC = 0.78, p < 0.001), while the severity of depressive symptoms as assessed by the EPDS during pregnancy affected that at 1 month postnatal (SPC = 0.41, p < 0.001). The SPC for perinatal HA to postnatal depressive symptoms (SPC = 0.13, p = 0.014) was significant and higher than that for perinatal depressive symptoms to postnatal HA (SPC = 0.06, p = 0.087). Conclusion: The present results suggest that early intervention in pregnant women with a history of MDD or a high intensity of HA is important to prevent postnatal depressive symptoms.

    DOI: 10.3389/fpsyt.2019.00515

    Web of Science

    PubMed

    researchmap

  62. Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect. Reviewed International journal

    Masashi Ikeda, Atsushi Takahashi, Yoichiro Kamatani, Yukihide Momozawa, Takeo Saito, Kenji Kondo, Ayu Shimasaki, Kohei Kawase, Takaya Sakusabe, Yoshimi Iwayama, Tomoko Toyota, Tomoyasu Wakuda, Mitsuru Kikuchi, Nobuhisa Kanahara, Hidenaga Yamamori, Yuka Yasuda, Yuichiro Watanabe, Satoshi Hoya, Branko Aleksic, Itaru Kushima, Heii Arai, Manabu Takaki, Kotaro Hattori, Hiroshi Kunugi, Yuko Okahisa, Tohru Ohnuma, Norio Ozaki, Toshiyuki Someya, Ryota Hashimoto, Takeo Yoshikawa, Michiaki Kubo, Nakao Iwata

    Schizophrenia bulletin   Vol. 45 ( 4 ) page: 824 - 834   2019.7

     More details

    Publishing type:Research paper (scientific journal)  

    Genome-wide association studies (GWASs) have identified >100 susceptibility loci for schizophrenia (SCZ) and demonstrated that SCZ is a polygenic disorder determined by numerous genetic variants but with small effect size. We conducted a GWAS in the Japanese (JPN) population (a) to detect novel SCZ-susceptibility genes and (b) to examine the shared genetic risk of SCZ across (East Asian [EAS] and European [EUR]) populations and/or that of trans-diseases (SCZ, bipolar disorder [BD], and major depressive disorder [MDD]) within EAS and between EAS and EUR (trans-diseases/populations). Among the discovery GWAS subjects (JPN-SCZ GWAS: 1940 SCZ cases and 7408 controls) and replication dataset (4071 SCZ cases and 54479 controls), both comprising JPN populations, 3 novel susceptibility loci for SCZ were identified: SPHKAP (Pbest = 4.1 × 10-10), SLC38A3 (Pbest = 5.7 × 10-10), and CABP1-ACADS (Pbest = 9.8 × 10-9). Subsequent meta-analysis between our samples and those of the Psychiatric GWAS Consortium (PGC; EUR samples) and another study detected 12 additional susceptibility loci. Polygenic risk score (PRS) prediction revealed a shared genetic risk of SCZ across populations (Pbest = 4.0 × 10-11) and between SCZ and BD in the JPN population (P ~ 10-40); however, a lower variance-explained was noted between JPN-SCZ GWAS and PGC-BD or MDD within/across populations. Genetic correlation analysis supported the PRS results; the genetic correlation between JPN-SCZ and PGC-SCZ was ρ = 0.58, whereas a similar/lower correlation was observed between the trans-diseases (JPN-SCZ vs JPN-BD/EAS-MDD, rg = 0.56/0.29) or trans-diseases/populations (JPN-SCZ vs PGC-BD/MDD, ρ = 0.38/0.12). In conclusion, (a) Fifteen novel loci are possible susceptibility genes for SCZ and (b) SCZ "risk" effect is shared with other psychiatric disorders even across populations.

    DOI: 10.1093/schbul/sby140

    Web of Science

    Scopus

    PubMed

    researchmap

  63. Methylation analysis for postpartum depression: a case control study. Reviewed International journal

    Yukako Nakamura, Masahiro Nakatochi, Shohko Kunimoto, Takashi Okada, Branko Aleksic, Miho Toyama, Tomoko Shiino, Mako Morikawa, Aya Yamauchi, Akira Yoshimi, Yoko Furukawa-Hibi, Taku Nagai, Masako Ohara, Chika Kubota, Kiyofumi Yamada, Masahiko Ando, Norio Ozaki

    BMC psychiatry   Vol. 19 ( 1 ) page: 190 - 190   2019.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Postpartum depression (PPD) is a major depressive disorder that occurs after childbirth. Objective diagnostic and predictive methods for PPD are important for early detection and appropriate intervention. DNA methylation has been recognized as a potential biomarker for major depressive disorder. In this study, we used methylation analysis and peripheral blood to search for biomarkers that could to lead to the development a predictive method for PPD. METHODS: Study participants included 36 pregnant women (18 cases and 18 controls determined after childbirth). Genome-wide DNA methylation profiles were obtained by analysis with an Infinium Human Methylation 450BeadChip. The association of DNA methylation status at each DNA methylation site with PPD was assessed using linear regression analysis. We also conducted functional enrichment analysis of PPD using The Database for Annotation, Visualization and Integrated Discovery 6.8 to explore enriched functional-related gene groups for PPD. RESULTS: In the analysis with postpartum depressed state as an independent variable, the difference in methylation frequency between the postpartum non-depressed group and the postpartum depressed group was small, and sites with genome-wide significant differences were not confirmed. After analysis by The Database for Annotation, Visualization and Integrated Discovery 6.8, we revealed four gene ontology terms, including axon guidance, related to postpartum depression. CONCLUSIONS: These findings may help with the development of an objective predictive method for PPD.

    DOI: 10.1186/s12888-019-2172-x

    Scopus

    PubMed

    researchmap

  64. Effects of Snoezelen-Multisensory environment on CARS scale in adolescents and adults with autism spectrum disorder. Reviewed International journal

    Neda Novakovic, Milica Pejovic Milovancevic, Slavica Djukic Dejanovic, Branko Aleksic

    Research in developmental disabilities   Vol. 89   page: 51 - 58   2019.6

     More details

    Publishing type:Research paper (scientific journal)  

    BACKGROUND: New classification system Diagnostic and statistical manual of mental disorders. 5th ed.(DSM - 5) includes sensory problems as one of the symptoms in diagnostic profile of Autism Spectrum Disorder (ASD). Researching the effects of sensory integration treatment may improve new approaches to the individuals with ASD. The objective of this study is to determine the effects of Snoezelen, multisensory environment on the severity of ASD and stereotyped/repetitive behaviours in adolescents and adults using CARS scale. METHOD: The study involved 40 subjects with ASD associated with intellectual difficulties of both sexes, aged 15-35. The subjects were randomly divided into two groups: a control one (without treatment) and an experimental one (with treatment). The assessments were rated by CARS (Childhood Autism Rating Scale) before and after the three-month treatment. RESULTS: In the experimental group, there was a statistically significant difference of the total CARS score before and after the treatment (p < 0.0005). Comparing the results of both experimental and control groups, a statistically significant difference was found on total CARS score (p < 0.0005). Conslusion: The results in the present study indicate that the continual sessions in Snoezelen room had effects on reducing severity of ASD and repetitive and stereotyped behaviours on CARS scale.

    DOI: 10.1016/j.ridd.2019.03.007

    Web of Science

    Scopus

    PubMed

    researchmap

  65. Author Correction: Proteomic analysis of lymphoblastoid cell lines from schizophrenic patients. Reviewed International journal

    Akira Yoshimi, Shinnosuke Yamada, Shohko Kunimoto, Branko Aleksic, Akihiro Hirakawa, Mitsuki Ohashi, Yurie Matsumoto, Kazuhiro Hada, Norimichi Itoh, Yuko Arioka, Hiroki Kimura, Itaru Kushima, Yukako Nakamura, Tomoko Shiino, Daisuke Mori, Satoshi Tanaka, Shuko Hamada, Yukihiro Noda, Taku Nagai, Kiyofumi Yamada, Norio Ozaki

    Translational psychiatry   Vol. 9 ( 1 ) page: 146 - 146   2019.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The original Article required a few updates; one co-author name, which was given as Hiroki Kiumura, has been updated to Hiroki Kimura. Furthermore, supplementary information has been updated, and grant numbers have been added. These updates have been made to both the PDF and HTML versions of this Article.

    DOI: 10.1038/s41398-019-0479-5

    Scopus

    PubMed

    researchmap

  66. Joint Degree Program for Graduate Students at the Nagoya University Graduate School of Medicine. Reviewed

    Hideki Kasuya, Branko Aleksic, Seiji Sumigama, Itzel Bustos, Hitoki Hasegawa, Mika P Kasai, Miho Kobayashi, Yumiko Samizo

    Nagoya journal of medical science   Vol. 81 ( 2 ) page: 183 - 192   2019.5

     More details

    Publishing type:Research paper (scientific journal)  

    In a world of increasing academic mobility, most universities seek to give their students opportunities to experience education in different countries, which is especially true for senior research students. The Nagoya University Graduate School of Medicine started a joint degree program (JDP) for PhD students with the University of Adelaide, Faculty of Health Science (Australia) in 2015 and with Lund University Faculty of Medicine (Sweden) in 2017. Furthermore, we have started a new JDP with the University of Freiburg, Faculty of Medicine (Germany) in 2018. This article reports the issues specific to counterpart medical schools, including student's recruitment, the curriculum, and the general differences between each schools. JDPs are not only important for educational collaboration, but also as a strategy to encourage international research collaboration, which is a core criterion to a university's world-ranking reputation. Acquiring knowledge about educational strategies that are implemented in different foreign medical schools represents a unique opportunity to improve our own curriculum.

    DOI: 10.18999/nagjms.81.2.183

    Web of Science

    Scopus

    PubMed

    researchmap

  67. Proteomic analysis of lymphoblastoid cell lines from schizophrenic patients. Reviewed International journal

    Akira Yoshimi, Shinnosuke Yamada, Shohko Kunimoto, Branko Aleksic, Akihiro Hirakawa, Mitsuki Ohashi, Yurie Matsumoto, Kazuhiro Hada, Norimichi Itoh, Yuko Arioka, Hiroki Kimura, Itaru Kushima, Yukako Nakamura, Tomoko Shiino, Daisuke Mori, Satoshi Tanaka, Shuko Hamada, Yukihiro Noda, Taku Nagai, Kiyofumi Yamada, Norio Ozaki

    Translational psychiatry   Vol. 9 ( 1 ) page: 126 - 126   2019.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Although a number of studies have identified several convincing candidate genes or molecules, the pathophysiology of schizophrenia (SCZ) has not been completely elucidated. Therapeutic optimization based on pathophysiology should be performed as early as possible to improve functional outcomes and prognosis; to detect useful biomarkers for SCZ, which reflect pathophysiology and can be utilized for timely diagnosis and effective therapy. To explore biomarkers for SCZ, we employed fluorescence two-dimensional differential gel electrophoresis (2D-DIGE) of lymphoblastoid cell lines (LCLs) (1st sample set: 30 SCZ and 30 CON). Differentially expressed proteins were sequenced by liquid chromatography tandem-mass spectrometry (LC-MS/MS) and identified proteins were confirmed by western blotting (WB) (1st and 2nd sample set: 60 SCZ and 60 CON). Multivariate logistic regression analysis was performed to identify an optimal combination of biomarkers to create a prediction model for SCZ. Twenty protein spots were differentially expressed between SCZ and CON in 2D-DIGE analysis and 22 unique proteins were identified by LC-MS/MS. Differential expression of eight of 22 proteins was confirmed by WB. Among the eight candidate proteins (HSPA4L, MX1, GLRX3, UROD, MAPRE1, TBCB, IGHM, and GART), we successfully constructed logistic regression models comprised of 4- and 6-markers with good discriminative ability between SCZ and CON. In both WB and gene expression analysis of LCL, MX1 showed reproducibly significant associations. Moreover, Mx1 and its related proinflamatory genes (Mx2, Il1b, and Tnf) were also up-regulated in poly I:C-treated mice. Differentially expressed proteins might be associated with molecular pathophysiology of SCZ, including dysregulation of immunological reactions and potentially provide diagnostic and prognostic biomarkers.

    DOI: 10.1038/s41398-019-0461-2

    Scopus

    PubMed

    researchmap

  68. A NOVEL RARE VARIANT R292H IN RTN4R AFFECTS GROWTH CONE FORMATION AND POSSIBLY CONTRIBUTES TO SCHIZOPHRENIA SUSCEPTIBILITY

    Kimura Hiroki, Ishizuka Kanako, Wang Chenyao, Kushima Itaru, Morikawa Mako, Uno Yota, Okada Takashi, Inanda Toshiya, Aleksic Branko, Mori Daisuke, Ozaki Norio

    EUROPEAN NEUROPSYCHOPHARMACOLOGY   Vol. 29   page: S1014 - S1014   2019

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.euroneuro.2017.08.415

    Web of Science

    researchmap

  69. INVESTIGATION OF NOVEL RARE VARIANTS IN NRXN1 CONTRIBUTES TO THE INCREASED RISK OF AUTISM SPECTRUM DISORDERS AND SCHIZOPHRENIA Reviewed International journal

    Ishizuka Kanako, Aleksic Branko, Ozaki Norio

    EUROPEAN NEUROPSYCHOPHARMACOLOGY   Vol. 29   page: S829 - S829   2019

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.euroneuro.2017.08.085

    Web of Science

  70. TARGET SEQUENCING OF GENES INVOLVED IN NEURODEVELOPMENT FROM WHOLE GENOME COPY NUMBER VARIATION ANALYSIS OF JAPANESE SCHIZOPHRENIA Reviewed International journal

    Kimura Hiroki, Aleksic Branko, Ishizuka Kanako, Wang Chenyao, Kushima Itaru, Ozaki Norio

    EUROPEAN NEUROPSYCHOPHARMACOLOGY   Vol. 29   page: 1334 - 1334   2019

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.euroneuro.2018.08.490

    Web of Science

  71. Stable factor structure of the Edinburgh Postnatal Depression Scale during the whole peripartum period: Results from a Japanese prospective cohort study. Reviewed International journal

    Chika Kubota, Toshiya Inada, Yukako Nakamura, Tomoko Shiino, Masahiko Ando, Branko Aleksic, Aya Yamauchi, Mako Morikawa, Takashi Okada, Masako Ohara, Maya Sato, Satomi Murase, Setsuko Goto, Atsuko Kanai, Norio Ozaki

    Scientific reports   Vol. 8 ( 1 ) page: 17659 - 17659   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Early detection of perinatal depression is an urgent issue. Our study aimed to examine the construct validity and factor structure of the Japanese version of the Edinburgh Postnatal Depression Scale (EPDS) from a prospective cohort study from pregnancy to postpartum. A total of 1075 women completed all items of the EPDS at four time points: early pregnancy, late pregnancy, 5 days postpartum and 1 month postpartum. The participants were randomly divided into two sample sets. The first sample set (n = 304) was used for exploratory factor analysis, and the second sample set (n = 771) was used for confirmatory factor analysis. As a result, the Cronbach's alpha coefficients of the EPDS items were 0.762, 0.740, 0.765 and 0.772 at the four time points. From the confirmatory factor analysis of the EPDS in a sample set of Japanese women from pregnancy to postpartum, the following three factors were detected: depression (items 7, 9), anxiety (items 4, 5) and anhedonia (items 1, 2). In conclusion, the EPDS is a useful rating scale, and its factor structure is consistently stable during the whole peripartum period.

    DOI: 10.1038/s41598-018-36101-z

    Scopus

    PubMed

    researchmap

  72. Dysregulation of schizophrenia-related aquaporin 3 through disruption of paranode influences neuronal viability. Reviewed International journal

    Kazuo Kunisawa, Takeshi Shimizu, Itaru Kushima, Branko Aleksic, Daisuke Mori, Yasuyuki Osanai, Kenta Kobayashi, Anna M Taylor, Manzoor A Bhat, Akiko Hayashi, Hiroko Baba, Norio Ozaki, Kazuhiro Ikenaka

    Journal of neurochemistry   Vol. 147 ( 3 ) page: 395 - 408   2018.11

     More details

    Publishing type:Research paper (scientific journal)  

    Myelinated axons segregate the axonal membrane into four defined regions: the node of Ranvier, paranode, juxtaparanode, and internode. The paranodal junction consists of specific component proteins, such as neurofascin155 (NF155) on the glial side, and Caspr and Contactin on the axonal side. Although paranodal junctions are thought to play crucial roles in rapid saltatory conduction and nodal assembly, the role of their interaction with neurons is not fully understood. In a previous study, conditional NF155 knockout in oligodendrocytes led to disorganization of the paranodal junctions. To examine if disruption of paranodal junctions affects neuronal gene expression, we prepared total RNA from the retina of NF155 conditional knockout, and performed expression analysis. We found that the expression level of 433 genes changed in response to paranodal junction ablation. Interestingly, expression of aquaporin 3 (AQP3) was significantly reduced in NF155 conditional knockout mice, but not in cerebroside sulfotransferase knockout (CST-KO) mice, whose paranodes are not originally formed during development. Copy number variations have an important role in the etiology of schizophrenia (SCZ). We observed rare duplications of AQP3 in SCZ patients, suggesting a correlation between abnormal AQP3 expression and SCZ. To determine if AQP3 over-expression in NF155 conditional knockout mice influences neuronal function, we performed adeno-associated virus (AAV)-mediated over-expression of AQP3 in the motor cortex of mice and found a significant increase in caspase 3-dependent neuronal apoptosis in AQP3-transduced cells. This study may provide new insights into therapeutic approaches for SCZ by regulating AQP3 expression, which is associated with paranodal disruption.

    DOI: 10.1111/jnc.14553

    Web of Science

    Scopus

    PubMed

    researchmap

  73. Assessment of a glyoxalase I frameshift variant, p.P122fs, in Japanese patients with schizophrenia. Reviewed International journal

    Kanako Ishizuka, Hiroki Kimura, Itaru Kushima, Toshiya Inada, Yuko Okahisa, Masashi Ikeda, Nakao Iwata, Daisuke Mori, Branko Aleksic, Norio Ozaki

    Psychiatric genetics   Vol. 28 ( 5 ) page: 90 - 93   2018.10

     More details

    Publishing type:Research paper (scientific journal)  

    Enhanced carbonyl stress has been observed in a subgroup of patients with schizophrenia. Glyoxalase I, which is encoded by GLO1, is an enzyme that protects against carbonyl stress. In this study, we focused on the association between rare genetic variants of GLO1 and schizophrenia. First, we identified one heterozygous frameshift variant, p.P122fs, in 370 Japanese schizophrenia cases with allele frequencies of up to 1% by exon-targeted mutation screening of GLO1. We then performed an association analysis on 1282 cases and 1764 controls with this variant. The variant was found in three cases and eight controls. There was no statistically significant association between p.P122fs in GLO1 and schizophrenia (P=0.25). This frameshift variant in GLO1 might occur at near-polymorphic frequencies in the Japanese population, although further investigations using larger samples and biological analyses are needed to exclude the possibility of a low-penetrance genetic risk associated with this variant.

    DOI: 10.1097/YPG.0000000000000204

    Web of Science

    Scopus

    PubMed

    researchmap

  74. Impact of perceived rearing and social support on bonding failure and depression among mothers: A longitudinal study of pregnant women. Reviewed International journal

    Masako Ohara, Masahiro Nakatochi, Takashi Okada, Branko Aleksic, Yukako Nakamura, Tomoko Shiino, Aya Yamauchi, Chika Kubota, Mako Morikawa, Satomi Murase, Setsuko Goto, Atsuko Kanai, Ryuji Kato, Masahiko Ando, Norio Ozaki

    Journal of psychiatric research   Vol. 105   page: 71 - 77   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Although previous studies have reported associations between bonding failure, depression, social support among mothers, and perceived rearing, the causal relationships remain unclear. METHODS: A total of 855 women (mean age, 32.4 ± 4.4 years) completed the Mother-Infant Bonding Questionnaire (MIBQ), the Edinburgh Postnatal Depression Scale (EPDS), the Japanese version of the Social Support Questionnaire, and the Parental Bonding Instrument in early pregnancy before week 25 (T1) and at 1 month after delivery (T2). We created a path model to clarify the causal relationships between perinatal bonding failure, depression, social support, and perceived rearing during pregnancy and at 1 month after delivery. The model was tested using structural equation modeling. RESULTS: Our recursive model showed acceptable fit (chi-squared statistic/degree of freedom = 2.1, comparative fit index = 0.98, root mean square error of approximation = 0.04). It was revealed that: (1) at T1, higher overprotection significantly predicted MIBQ scores; (2) at T1, poorer social support significantly predicted both MIBQ and EPDS scores; and (3) at T1, both MIBQ and EPDS scores significantly predicted respective scores at T2. CONCLUSIONS: These results showed that bonding failure in the postpartum period was significantly influenced by mothers' own perceived rearing and social support during pregnancy. In addition, depression in the postpartum period was strongly influenced by social support during pregnancy. These findings suggest that psychosocial interventions that focus on both mothers' recollections of their own upbringing and social support during pregnancy are effective for preventing bonding failure and depression in the postpartum period.

    DOI: 10.1016/j.jpsychires.2018.09.001

    Scopus

    PubMed

    researchmap

  75. The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers. Reviewed International journal

    Ibrahim Ragab Eissa, Itzel Bustos-Villalobos, Toru Ichinose, Shigeru Matsumura, Yoshinori Naoe, Noriyuki Miyajima, Daishi Morimoto, Nobuaki Mukoyama, Wu Zhiwen, Maki Tanaka, Hitoki Hasegawa, Seiji Sumigama, Branko Aleksic, Yasuhiro Kodera, Hideki Kasuya

    Cancers   Vol. 10 ( 10 )   2018.10

     More details

    Publishing type:Research paper (scientific journal)  

    Oncolytic viral therapy has been accepted as a standard immunotherapy since talimogene laherparepvec (T-VEC, Imlygic®) was approved by the Food and Drug Administration (FDA) and European Medicines Agency (EMA) for melanoma treatment in 2015. Various oncolytic viruses (OVs), such as HF10 (Canerpaturev-C-REV) and CVA21 (CAVATAK), are now actively being developed in phase II as monotherapies, or in combination with immune checkpoint inhibitors against melanoma. Moreover, in glioma, several OVs have clearly demonstrated both safety and a promising efficacy in the phase I clinical trials. Additionally, the safety of several OVs, such as pelareorep (Reolysin®), proved their safety and efficacy in combination with paclitaxel in breast cancer patients, but the outcomes of OVs as monotherapy against breast cancer have not provided a clear therapeutic strategy for OVs. The clinical trials of OVs against pancreatic cancer have not yet demonstrated efficacy as either monotherapy or as part of combination therapy. However, there are several oncolytic viruses that have successfully proved their efficacy in different preclinical models. In this review, we mainly focused on the oncolytic viruses that transitioned into clinical trials against melanoma, glioma, pancreatic, and breast cancers. Hence, we described the current status and future prospects of OVs clinical trials against melanoma, glioma, pancreatic, and breast cancers.

    DOI: 10.3390/cancers10100356

    Web of Science

    Scopus

    PubMed

    researchmap

  76. Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights. Reviewed International journal

    Itaru Kushima, Branko Aleksic, Masahiro Nakatochi, Teppei Shimamura, Takashi Okada, Yota Uno, Mako Morikawa, Kanako Ishizuka, Tomoko Shiino, Hiroki Kimura, Yuko Arioka, Akira Yoshimi, Yuto Takasaki, Yanjie Yu, Yukako Nakamura, Maeri Yamamoto, Tetsuya Iidaka, Shuji Iritani, Toshiya Inada, Nanayo Ogawa, Emiko Shishido, Youta Torii, Naoko Kawano, Yutaka Omura, Toru Yoshikawa, Tokio Uchiyama, Toshimichi Yamamoto, Masashi Ikeda, Ryota Hashimoto, Hidenaga Yamamori, Yuka Yasuda, Toshiyuki Someya, Yuichiro Watanabe, Jun Egawa, Ayako Nunokawa, Masanari Itokawa, Makoto Arai, Mitsuhiro Miyashita, Akiko Kobori, Michio Suzuki, Tsutomu Takahashi, Masahide Usami, Masaki Kodaira, Kyota Watanabe, Tsukasa Sasaki, Hitoshi Kuwabara, Mamoru Tochigi, Fumichika Nishimura, Hidenori Yamasue, Yosuke Eriguchi, Seico Benner, Masaki Kojima, Walid Yassin, Toshio Munesue, Shigeru Yokoyama, Ryo Kimura, Yasuko Funabiki, Hirotaka Kosaka, Makoto Ishitobi, Tetsuro Ohmori, Shusuke Numata, Takeo Yoshikawa, Tomoko Toyota, Kazuhiro Yamakawa, Toshimitsu Suzuki, Yushi Inoue, Kentaro Nakaoka, Yu-Ichi Goto, Masumi Inagaki, Naoki Hashimoto, Ichiro Kusumi, Shuraku Son, Toshiya Murai, Tempei Ikegame, Naohiro Okada, Kiyoto Kasai, Shohko Kunimoto, Daisuke Mori, Nakao Iwata, Norio Ozaki

    Cell reports   Vol. 24 ( 11 ) page: 2838 - 2856   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Compelling evidence in Caucasian populations suggests a role for copy-number variations (CNVs) in autism spectrum disorder (ASD) and schizophrenia (SCZ). We analyzed 1,108 ASD cases, 2,458 SCZ cases, and 2,095 controls in a Japanese population and confirmed an increased burden of rare exonic CNVs in both disorders. Clinically significant (or pathogenic) CNVs, including those at 29 loci common to both disorders, were found in about 8% of ASD and SCZ cases, which was significantly higher than in controls. Phenotypic analysis revealed an association between clinically significant CNVs and intellectual disability. Gene set analysis showed significant overlap of biological pathways in both disorders including oxidative stress response, lipid metabolism/modification, and genomic integrity. Finally, based on bioinformatics analysis, we identified multiple disease-relevant genes in eight well-known ASD/SCZ-associated CNV loci (e.g., 22q11.2, 3q29). Our findings suggest an etiological overlap of ASD and SCZ and provide biological insights into these disorders.

    DOI: 10.1016/j.celrep.2018.08.022

    Scopus

    PubMed

    researchmap

  77. Aberrant functional connectivity between the thalamus and visual cortex is related to attentional impairment in schizophrenia

    Yamamoto Maeri, Kushima Itaru, Suzuki Ryohei, Branko Aleksic, Kawano Naoko, Inada Toshiya, Iidaka Tetsuya, Ozaki Norio

    PSYCHIATRY RESEARCH-NEUROIMAGING   Vol. 278   page: 35 - 41   2018.8

  78. Genetic and animal model analyses reveal the pathogenic role of a novel deletion of RELN in schizophrenia. Reviewed International journal

    Akira Sobue, Itaru Kushima, Taku Nagai, Wei Shan, Takao Kohno, Branko Aleksic, Yuki Aoyama, Daisuke Mori, Yuko Arioka, Naoko Kawano, Maeri Yamamoto, Mitsuharu Hattori, Toshitaka Nabeshima, Kiyofumi Yamada, Norio Ozaki

    Scientific reports   Vol. 8 ( 1 ) page: 13046 - 13046   2018.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Reelin protein (RELN), an extracellular matrix protein, plays multiple roles that range from embryonic neuronal migration to spine formation in the adult brain. Results from genetic studies have suggested that RELN is associated with the risk of psychiatric disorders, including schizophrenia (SCZ). We previously identified a novel exonic deletion of RELN in a patient with SCZ. High-resolution copy number variation analysis revealed that this deletion included exons 52 to 58, which truncated the RELN in a similar manner to the Reln Orleans mutation (Relnrl-Orl). We examined the clinical features of this patient and confirmed a decreased serum level of RELN. To elucidate the pathophysiological role of the exonic deletion of RELN in SCZ, we conducted behavioral and neurochemical analyses using heterozygous Relnrl-Orl/+ mice. These mice exhibited abnormalities in anxiety, social behavior, and motor learning; the deficits in motor learning were ameliorated by antipsychotics. Methamphetamine-induced hyperactivity and dopamine release were significantly reduced in the Relnrl-Orl/+ mice. In addition, the levels of GABAergic markers were decreased in the brain of these mice. Taken together, our results suggest that the exonic deletion of RELN plays a pathological role, implicating functional changes in the dopaminergic and GABAergic systems, in the pathophysiology of SCZ.

    DOI: 10.1038/s41598-018-31390-w

    Scopus

    PubMed

    researchmap

  79. Postpartum depression among women in Nagoya indirectly exposed to the Great East Japan Earthquake. Reviewed International journal

    Chika Kubota, Takashi Okada, Mako Morikawa, Yukako Nakamura, Aya Yamauchi, Masahiko Ando, Tomoko Shiino, Masako Ohara, Satomi Murase, Setsuko Goto, Atsuko Kanai, Tomoko Masuda, Branko Aleksic, Norio Ozaki

    Scientific reports   Vol. 8 ( 1 ) page: 11624 - 11624   2018.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    This study aimed to assess the situation of postpartum depression and maternal bonding in Nagoya, a city distant from the epicenter of the Great East Japan Earthquake that occurred on March 11, 2011. Among the participants at 1 month after childbirth between March 11, 2010 and March 10, 2013 (n = 188), 152 fully responded to the Edinburgh Postnatal Depression Scale (EPDS) and Mother-Infant Bonding Questionnaire (MIBQ). They were divided into pre-quake (n = 58), and 0-6, 6-12, 12-18, and 18-24 months after the earthquake groups (n = 20, 26, 29, and 19, respectively). The rate of mothers who scored above the cutoff point for the EPDS increased from 12.1% in the pre-quake to 35.0% in the 0-6 months group (p = 0.022). The EPDS total and anxiety subscale scores (mean ± standard error) were also significantly different between the pre-quake and 0-6 months after the earthquake groups (4.45 ± 0.50 vs. 7.95 ± 1.47, p = 0.024; 2.16 ± 0.26 vs. 3.65 ± 0.57, p = 0.021, respectively). The EPDS total and anxiety scores were the highest for the 0-6 months group, followed by the 6-12, 12-18, 18-24 months groups (p = 0.019, p = 0.022). MIBQ scores did not differ between the pre-quake and 0-6 months groups. Depressive symptoms, mainly explained by anxiety, increased after the earthquake with no changes in maternal bonding.

    DOI: 10.1038/s41598-018-30065-w

    Scopus

    PubMed

    researchmap

  80. Single-cell trajectory analysis of human homogenous neurons carrying a rare RELN variant. Reviewed International journal

    Yuko Arioka, Emiko Shishido, Hisako Kubo, Itaru Kushima, Akira Yoshimi, Hiroki Kimura, Kanako Ishizuka, Branko Aleksic, Takuji Maeda, Mitsuru Ishikawa, Naoko Kuzumaki, Hideyuki Okano, Daisuke Mori, Norio Ozaki

    Translational psychiatry   Vol. 8 ( 1 ) page: 129 - 129   2018.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Reelin is a protein encoded by the RELN gene that controls neuronal migration in the developing brain. Human genetic studies suggest that rare RELN variants confer susceptibility to mental disorders such as schizophrenia. However, it remains unknown what effects rare RELN variants have on human neuronal cells. To this end, the analysis of human neuronal dynamics at the single-cell level is necessary. In this study, we generated human-induced pluripotent stem cells carrying a rare RELN variant (RELN-del) using targeted genome editing; cells were further differentiated into highly homogeneous dopaminergic neurons. Our results indicated that RELN-del triggered an impaired reelin signal and decreased the expression levels of genes relevant for cell movement in human neurons. Single-cell trajectory analysis revealed that control neurons possessed directional migration even in vitro, while RELN-del neurons demonstrated a wandering type of migration. We further confirmed these phenotypes in neurons derived from a patient carrying the congenital RELN-del. To our knowledge, this is the first report of the biological significance of a rare RELN variant in human neurons based on individual neuron dynamics. Collectively, our approach should be useful for studying reelin function and evaluating mental disorder susceptibility, focusing on individual human neuronal migration.

    DOI: 10.1038/s41398-018-0177-8

    Scopus

    PubMed

    researchmap

  81. Driving performance of stable outpatients with depression undergoing real-world treatment. Reviewed International journal

    Akemi Miyata, Kunihiro Iwamoto, Naoko Kawano, Branko Aleksic, Masahiko Ando, Kazutoshi Ebe, Kiyoshi Fujita, Motonori Yokoyama, Tsuyoshi Akiyama, Yoshio Igarashi, Norio Ozaki

    Psychiatry and clinical neurosciences   Vol. 72 ( 6 ) page: 399 - 408   2018.6

     More details

    Publishing type:Research paper (scientific journal)  

    AIM: Although the effects of psychotropics on driving ability have received much attention, little research is available on driving performance of stable outpatients with depression undergoing real-world treatment. This observational study investigated driving performance, cognitive functions, and depressive symptomatology of partly remitted outpatients with depression under daily-practice psychopharmacologic treatment. METHODS: Seventy stable outpatients with depression and 67 healthy volunteers were enrolled. Patients' prescriptions were not controlled in order to capture the real-world treatment environment. Participants underwent three driving tasks - road-tracking, car-following, and harsh-braking - using a driving simulator, and three cognitive tasks - Continuous Performance Test, Wisconsin Card Sorting Test, and Trail-Making Test. The Symptom Assessment Scale - Structured Interview Guide for the Hamilton Depression Rating Scale, Beck Depression Inventory-II, Social Adaptation Self-Evaluation Scale, and Stanford Sleepiness Scale were also completed. RESULTS: Although many patients received various pharmacologic treatments, there were no significant differences in the three driving tasks between outpatients with depression and healthy controls. Difficulty of maintaining set in the Wisconsin Card Sorting Test was significantly increased in patients with depression. Results on the Social Adaptation Self-Evaluation Scale were significantly associated with road-tracking and car-following performance, in contrast to results on the Hamilton Depression Rating Scale and the Beck Depression Inventory-II. CONCLUSION: We conclude that partly remitted depressive patients under steady-state pharmacologic treatment do not differ from healthy controls with respect to driving performance, which seems to be more affected by psychosocial functioning than by pharmacologic agents. This, however, should be investigated systematically in an off/on study.

    DOI: 10.1111/pcn.12648

    Web of Science

    Scopus

    PubMed

    researchmap

  82. Possible involvement of a cell adhesion molecule, Migfilin, in brain development and pathogenesis of autism spectrum disorders. Reviewed International journal

    Kanako Ishizuka, Hidenori Tabata, Hidenori Ito, Itaru Kushima, Mariko Noda, Akira Yoshimi, Masahide Usami, Kyota Watanabe, Mako Morikawa, Yota Uno, Takashi Okada, Daisuke Mori, Branko Aleksic, Norio Ozaki, Koh-Ichi Nagata

    Journal of neuroscience research   Vol. 96 ( 5 ) page: 789 - 802   2018.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Migfilin, encoded by FBLIM1 at the 1p36 locus, is a multi-domain adaptor protein essential for various cellular processes such as cell morphology and migration. Small deletions and duplications at the 1p36 locus, monosomy of which results in neurodevelopmental disorders and multiple congenital anomalies, have also been identified in patients with autism spectrum disorder (ASD). However, the impact of FBLIM1, the gene within 1p36, on the pathogenesis of ASD is unknown. In this study, we performed morphological analyses of migfilin to elucidate its role in brain development. Migfilin was detected specifically in the embryonic and perinatal stages of the mouse brain. Either silencing or overexpression of migfilin in embryos following in utero electroporation disrupted Neocortical neuronal migration. Additionally, neurite elongation was impaired when migfilin was silenced in cultured mouse hippocampal neurons. We then screened FBLIM1 for rare exonic deletions/duplications in 549 Japanese ASD patients and 824 controls, detecting one case of ASD and intellectual delay that harbored a 26-kb deletion at 1p36.21 that solely included the C-terminal exon of FBLIM1. The FBLIM1 mRNA expression level in this case was reduced compared to levels in individuals without FBLIM1 deletion. Our findings indicate that tightly regulated expression of migfilin is essential for neuronal development and that FBLIM1 disruption may be related to the phenotypes associated with ASD and related neurodevelopmental disorders.

    DOI: 10.1002/jnr.24194

    Scopus

    PubMed

    researchmap

  83. Assessment of a GLO1 frameshift variant, c.365delC, in Japanese cases of schizophrenia and controls Reviewed International journal

    Ishizuka Kanako, Aleksic Branko, Ozaki Norio

    HUMAN GENOMICS   Vol. 12   2018.3

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

  84. Whole exome sequencing of 14 schizophrenia multiplex families in Japan Reviewed International journal

    Toyama Miho, Takasaki Yuto, Aleksic Branko, Ogi Tomoo, Ozaki Norio

    HUMAN GENOMICS   Vol. 12   2018.3

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

    researchmap

  85. Whole exome sequencing of 14 schizophrenia multiplex families in Japan Reviewed International journal

    Toyama Miho, Takasaki Yuto, Aleksic Branko, Ogi Tomoo, Ozaki Norio

    HUMAN GENOMICS   Vol. 12   2018.3

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

  86. Issues on the diagnosis and etiopathogenesis of mood disorders: reconsidering DSM-5 Reviewed International journal

    Kazuyoshi Ogasawara, Yukako Nakamura, Hiroyuki Kimura, Branko Aleksic, Norio Ozaki

    Journal of Neural Transmission   Vol. 125 ( 2 ) page: 211 - 222   2018.2

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer-Verlag Wien  

    The authors present a narrative review from the diagnostic and nosologic viewpoints of mood disorders (bipolar and depressive ones) by revisiting the revision from the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders, Text Revision to DSM-5, including the following: the separation of the bipolar and depressive sections
    the addition of increased energy and continuation of symptoms to the hypo/manic criteria
    the elimination of mixed episodes
    the creation of new categories and specifiers (“other specified bipolar and related disorder”, “disruptive mood dysregulation disorder”, “with anxious distress”, “with mixed features”, “with peripartum onset”)
    the categorization of hypo/manic episodes during antidepressant treatment into bipolar disorder
    the elimination of the “bereavement exclusion”
    the ambiguous separation between bipolar I and II
    the insufficient distinction between “other specified bipolar and related disorders” and major depressive disorder
    the differentiation regarding borderline personality disorder
    agitation
    premenstrual dysphoric disorder
    and society and psychiatry. Through this analysis, we point out both the achievements and limitations of DSM-5. In addition, to examine the future direction of psychiatry, we introduce our cohort study regarding maternal depression and an outline of the National Institute of Mental Health’s Research Domain Criteria project in the US. Finally, we advocate the importance of elucidating etiopathogeneses by starting from or going beyond the DSM operational diagnostic system, which has shown great efficacy.

    DOI: 10.1007/s00702-017-1828-2

    Web of Science

    Scopus

    PubMed

    researchmap

  87. Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility. Reviewed International journal

    Yanjie Yu, Yingni Lin, Yuto Takasaki, Chenyao Wang, Hiroki Kimura, Jingrui Xing, Kanako Ishizuka, Miho Toyama, Itaru Kushima, Daisuke Mori, Yuko Arioka, Yota Uno, Tomoko Shiino, Yukako Nakamura, Takashi Okada, Mako Morikawa, Masashi Ikeda, Nakao Iwata, Yuko Okahisa, Manabu Takaki, Shinji Sakamoto, Toshiyuki Someya, Jun Egawa, Masahide Usami, Masaki Kodaira, Akira Yoshimi, Tomoko Oya-Ito, Branko Aleksic, Kinji Ohno, Norio Ozaki

    Translational psychiatry   Vol. 8 ( 1 ) page: 12 - 12   2018.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    In schizophrenia (SCZ) and autism spectrum disorder (ASD), the dysregulation of glutamate transmission through N-methyl-D-aspartate receptors (NMDARs) has been implicated as a potential etiological mechanism. Previous studies have accumulated evidence supporting NMDAR-encoding genes' role in etiology of SCZ and ASD. We performed a screening study for exonic regions of GRIN1, GRIN2A, GRIN2C, GRIN2D, GRIN3A, and GRIN3B, which encode NMDAR subunits, in 562 participates (370 SCZ and 192 ASD). Forty rare variants were identified including 38 missense, 1 frameshift mutation in GRIN2C and 1 splice site mutation in GRIN2D. We conducted in silico analysis for all variants and detected seven missense variants with deleterious prediction. De novo analysis was conducted if pedigree samples were available. The splice site mutation in GRIN2D is predicted to result in intron retention by minigene assay. Furthermore, the frameshift mutation in GRIN2C and splice site mutation in GRIN2D were genotyped in an independent sample set comprising 1877 SCZ cases, 382 ASD cases, and 2040 controls. Both of them were revealed to be singleton. Our study gives evidence in support of the view that ultra-rare variants with loss of function (frameshift, nonsense or splice site) in NMDARs genes may contribute to possible risk of SCZ.

    DOI: 10.1038/s41398-017-0061-y

    Scopus

    PubMed

    researchmap

  88. Genetics in pediatric consultation-liaison psychiatry and multidisciplinary management of complex conditions Reviewed International journal

    Aleksic B.

    Pediatric Consultation-Liaison Psychiatry: A Global, Healthcare Systems-Focused, and Problem-Based Approach     page: 251 - 264   2018.1

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Pediatric Consultation-Liaison Psychiatry: A Global, Healthcare Systems-Focused, and Problem-Based Approach  

    DOI: 10.1007/978-3-319-89488-1_14

    Scopus

  89. CLINICALLY RELEVANT GENETIC VARIANTS: MODELS FOR UNDERSTANDING SCHIZOPHRENIA AND OTHER NEUROPSYCHIATRIC DISORDERS DUPLICATIONS AT 15Q11-Q13 IN SCHIZOPHRENIA AND NEURODEVELOPMENTAL DISORDERS Reviewed International journal

    Kirov George, Isles Anthony, Ingason Andres, Lowther Chelsea, Walters James, Bassett Anne, Costain Gregory, Levinson Douglas, Gawlick Micha, Degenhardt Franziska, Aleksic Branko, Ahn JooWook, Ogilvie Caroline, Stefansson Kari, Owen Michael

    EUROPEAN NEUROPSYCHOPHARMACOLOGY   Vol. 27   page: S277 - S277   2017.10

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

  90. IDENTIFICATION OF RARE DISRUPTIVE VARIANTS IN VOLTAGE-GATED CHANNEL GENES (CACNA1C, CACNA1D, CACNA1S, CACNA1I) IN JAPANESE SAMPLES OF SCHIZOPHRENIA AND AUTISM SPECTRUM DISORDER USING ION TORRENT PGM PLATFORM Reviewed International journal

    Wang Chenyao, Kimura Hiroki, Xing Jingrui, Ishizuka Kanoko, Kushima Itaru, Arioka Yuko, Yoshimi Akira, Nakamura Yukako, Shiino Yomoko, Oya Yuko, Takasaki Yuto, Aleksic Branko, Mori Daisuke, Ozaki Norio

    EUROPEAN NEUROPSYCHOPHARMACOLOGY   Vol. 27   page: S341 - S342   2017.10

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

  91. Relationship between maternal depression and bonding failure: A prospective cohort study of pregnant women Reviewed International journal

    Masako Ohara, Takashi Okada, Chika Kubota, Yukako Nakamura, Tomoko Shiino, Branko Aleksic, Mako Morikawa, Aya Yamauchi, Yota Uno, Satomi Murase, Setsuko Goto, Atsuko Kanai, Tomoko Masuda, Masahiko Ando, Norio Ozaki

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   Vol. 71 ( 10 ) page: 733 - 741   2017.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    Aim: Although the association between maternal depression and bonding failure during pregnancy and after delivery has been investigated, the causal relationships remain unclear.
    Methods: A total of 751 women (mean [SD] age, 32.1 [4.4] years) completed the Mother-Infant Bonding Questionnaire and the Edinburgh Postnatal Depression Scale during early pregnancy before week 25 (T1), during late pregnancy around week 36 (T2), and at 5 days after delivery (T3). We created a structural regression model to clarify the relationships between depressive mood and bonding failure during pregnancy and at 5 days after delivery. The model was tested with structural equation modeling.
    Results: Our non-recursive model fit the data well, and we found that: (i) during T2, bonding failure predicted depressive mood (P &lt; 0.01, r = 0.23); (ii) at T3, bonding failure predicted depressive mood (P &lt; 0.05, r = 0.31); (iii) during T1, depressive mood was correlated with bonding failure (P &lt; 0.01, r = 0.45); (iv) depressive mood during T1 predicted depressive mood during T2 (P &lt; 0.01, r = 0.58); (v) depressive mood during T2 predicted depressive mood at T3 (P &lt; 0.01, r = 0.45); (vi) bonding failure during T1 predicted bonding failure during T2 (P &lt; 0.01, r = 0.84); and (vii) bonding failure during T2 predicted bonding failure at T3 (P &lt; 0.01, r = 0.44). The determinant coefficients of depressive mood and bonding failure at T3 were 0.41 and 0.28, respectively.
    Conclusion: Our large-scale cohort study indicates that bonding failure predicts depressive mood during pregnancy and 5 days after delivery. These findings suggest that protection and support for pregnant women with depressive mood and bonding failure may prevent both issues during pregnancy and the early stage after delivery.

    DOI: 10.1111/pcn.12541

    Web of Science

    Scopus

    PubMed

    researchmap

  92. MUTATION SCREENING OF THE PCDH15 GENE IN PATIENTS SUFFERING FROM AUTISM SPECTRUM DISORDERS AND SCHIZOPHRENIA Reviewed International journal

    Ishizuka Kanako, Wang Chenyao, Kimura Hiroki, Xing Jingrui, Kushima Itaru, Arioka Yuko, Yoshimi Akira, Nakamura Yukako, Oya-Ito Tomoko, Takasaki Yuto, Uno Yota, Okada Takashi, Mori Daisuke, Aleksic Branko, Ozaki Norio

    EUROPEAN NEUROPSYCHOPHARMACOLOGY   Vol. 27   page: S162 - S163   2017.10

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

  93. Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder Reviewed International journal

    Elaine T. Lim, Mohammed Uddin, Silvia De Rubeis, Yingleong Chan, Anne S. Kamumbu, Xiaochang Zhang, Alissa M. D'Gama, Sonia N. Kim, Robert Sean Hill, Arthur P. Goldberg, Christopher Poultney, Nancy J. Minshew, Itaru Kushima, Branko Aleksic, Norio Ozaki, Mara Parellada, Celso Arango, Maria J. Penzol, Angel Carracedo, Alexander Kolevzon, Christina M. Hultman, Lauren A. Weiss, Menachem Fromer, Andreas G. Chiocchetti, Christine M. Freitag, George M. Church, Stephen W. Scherer, Joseph D. Buxbaum, Christopher A. Walsh

    NATURE NEUROSCIENCE   Vol. 20 ( 9 ) page: 1217 - +   2017.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    We systematically analyzed postzygotic mutations (PZMs) in whole-exome sequences from the largest collection of trios (5,947) with autism spectrum disorder (ASD) available, including 282 unpublished trios, and performed resequencing using multiple independent technologies. We identified 7.5% of de novo mutations as PZMs, 83.3% of which were not described in previous studies. Damaging, nonsynonymous PZMs within critical exons of prenatally expressed genes were more common in ASD probands than controls (P &lt; 1 x 10(-6)), and genes carrying these PZMs were enriched for expression in the amygdala (P = 5.4 x 10(-3)). Two genes (KLF16 and MSANTD2) were significantly enriched for PZMs genome-wide, and other PZMs involved genes (SCN2A, HNRNPU and SMARCA4) whose mutation is known to cause ASD or other neurodevelopmental disorders. PZMs constitute a significant proportion of de novo mutations and contribute importantly to ASD risk.

    DOI: 10.1038/nn.4598

    Web of Science

    Scopus

    PubMed

    researchmap

  94. A novel rare variant R292H in RTN4R affects growth cone formation and possibly contributes to schizophrenia susceptibility

    Kimura H., Fujita Y., Kawabata T., Ishizuka K., Wang C., Iwayama Y., Okahisa Y., Kushima I., Morikawa M., Uno Y., Okada T., Ikeda M., Inada T., Branko A., Mori D., Yoshikawa T., Iwata N., Nakamura H., Yamashita T., Ozaki N.

    TRANSLATIONAL PSYCHIATRY   Vol. 7   2017.8

  95. Social support helps protect against perinatal bonding failure and depression among mothers: a prospective cohort study Reviewed International journal

    Masako Ohara, Takashi Okada, Branko Aleksic, Mako Morikawa, Chika Kubota, Yukako Nakamura, Tomoko Shiino, Aya Yamauchi, Yota Uno, Satomi Murase, Setsuko Goto, Atsuko Kanai, Tomoko Masuda, Masahiro Nakatochi, Masahiko Ando, Norio Ozaki

    SCIENTIFIC REPORTS   Vol. 7 ( 1 ) page: 9546   2017.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Causal relationships between perinatal bonding failure, depression, and social support among mothers remain unclear. A total of 494 women (mean age 32.4 +/- 4.5 years) completed the Mother-Infant Bonding Questionnaire (MIBQ), the Edinburgh Postnatal Depression Scale (EPDS), and the Japanese version of the Social Support Questionnaire in early pregnancy before week 25 (T1) and 1 month after delivery (T2). Our model of recursive structured equation modeling (SEM) showed acceptable fit (CMIN/df = 2.2, CFI = 0.97, and RMSEA = 0.05). It was revealed that: (1) a lower number of supportive persons at T1 significantly predicted both MIBQ and EPDS scores at T1 and T2; (2) at T1, poorer satisfaction with the social support received significantly predicted EPDS scores; (3) both MIBQ and EPDS scores at T1 significantly predicted their respective scores at T2. Out cohort study indicates that the number of individuals who are available to provide social support and the degree of satisfaction with the level of social support received during pregnancy have a great influence on bonding failure and depression in the postpartum period. These findings suggest that psychosocial interventions that focus on these two aspects of social support during pregnancy are effective in preventing bonding failure and depression in the postpartum period.

    DOI: 10.1038/s41598-017-08768-3

    Web of Science

    Scopus

    PubMed

    researchmap

  96. Genomic signature of the natural oncolytic herpes simplex virus HF10 and its therapeutic role in preclinical and clinical trials Reviewed International journal

    Ibrahim Ragab Eissa, Yoshinori Naoe, Itzel Bustos-Villalobos, Toru Ichinose, Maki Tanaka, Wu Zhiwen, Nobuaki Mukoyama, Taishi Morimoto, Noriyuki Miyajima, Hasegawa Hitoki, Seiji Sumigama, Branko Aleksic, Yasuhiro Kodera, Hideki Kasuya

    Frontiers in Oncology   Vol. 7 ( JUL ) page: 149   2017.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media S.A.  

    Oncolytic viruses (OVs) are opening new possibilities in cancer therapy with their unique mechanism of selective replication within tumor cells and triggering of antitumor immune responses. HF10 is an oncolytic herpes simplex virus-1 with a unique genomic structure that has non-engineered deletions and insertions accompanied by frame-shift mutations, in contrast to the majority of engineered OVs. At the genetic level, HF10 naturally lacks the expression of UL43, UL49.5, UL55, UL56, and latency-associated transcripts, and overexpresses UL53 and UL54. In preclinical studies, HF10 replicated efficiently within tumor cells with extensive cytolytic effects and induced increased numbers of activated CD4+ and CD8+ T cells and natural killer cells within the tumor, leading to a significant reduction in tumor growth and prolonged survival rates. Investigator-initiated clinical studies of HF10 have been completed in recurrent breast carcinoma, head and neck cancer, and unresectable pancreatic cancer in Japan. Phase I trials were subsequently completed in refractory superficial cancers and melanoma in the United States. HF10 has been demonstrated to have a high safety margin with low frequency of adverse effects in all treated patients. Interestingly, HF10 antigens were detected in pancreatic carcinoma over 300 days after treatment with infiltration of CD4+ and CD8+ T cells, which enhanced the immune response. To date, preliminary results from a Phase II trial have indicated that HF10 in combination with ipilimumab (anti-CTLA-4) is safe and well tolerated, with high antitumor efficacy. Improvement of the effect of ipilimumab was observed in patients with stage IIIb, IIIc, or IV unresectable or metastatic melanoma. This review provides a concise description of the genomic functional organization of HF10 compared with talimogene laherparepvec. Furthermore, this review focuses on HF10 in cancer treatment as monotherapy as well as in combination therapy through a concise description of all preclinical and clinical data. In addition, we will address approaches for future directions in HF10 studies as cancer therapy.

    DOI: 10.3389/fonc.2017.00149

    Scopus

    PubMed

    researchmap

  97. Effect of Adjunctive Aripiprazole on Sexual Dysfunction in Schizophrenia: A Preliminary Open-Label Study Reviewed International journal

    Junko Fujioi, Kunihiro Iwamoto, Masahiro Banno, Tsutomu Kikuchi, Branko Aleksic, Norio Ozaki

    PHARMACOPSYCHIATRY   Vol. 50 ( 2 ) page: 74 - 78   2017.3

     More details

    Publishing type:Research paper (scientific journal)   Publisher:GEORG THIEME VERLAG KG  

    Introduction Although adjunctive aripiprazole improves hyperprolactinemia, sufficient evidence for its effects on sexual dysfunction has not been obtained. We assessed the usefulness of adjunctive aripiprazole for schizophrenia with sexual dysfunction.
    Methods 22 Japanese schizophrenia patients with antipsychotic-induced hyperprolactinemia and sexual dysfunction were enrolled, and 19 of them completed the study. Aripiprazole was administrated in a flexible titration schedule to participants according to the judgment of each doctor, and patients were followed for 24 weeks. Serum prolactin, Clinical Global Impression Scales-Severity (CGI-S), and Nagoya Sexual Function Questionnaire (NSFQ) were measured at baseline and at 4, 8, 12, and 24 weeks.
    Results Prolactin at week 4 and later was significantly lower than that at baseline. Compared to baseline, we observed a significant improvement in total sexual dysfunction as measured by NSFQ at week 8 and later. In males, erectile dysfunction was significantly reduced at week 24. In females, menstrual irregularity and galactorrhea were significantly reduced at week 24. CGI-S did not significantly change.
    Discussion Although the small sample size is a limitation in this study, adjunctive aripiprazole may be useful treatment for sexual dysfunction including hyperprolactinemia in schizophrenia.

    DOI: 10.1055/s-0042-116323

    Web of Science

    Scopus

    researchmap

    Other Link: http://orcid.org/0000-0002-2539-1031

  98. Schizophrenia polygenic risk score and prepubertal developmental impairments Reviewed International journal

    Branko Aleksic, Norio Ozaki

    The Lancet Psychiatry   Vol. 4 ( 1 ) page: 7 - 8   2017.1

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier Ltd  

    DOI: 10.1016/S2215-0366(16)30409-6

    Web of Science

    Scopus

    PubMed

    researchmap

  99. Serbian Language version of the Modified Checklist for Autism in Toddlers, Revised, with Follow-Up: Cross-Cultural Adaptation and Assessment of Reliability Reviewed International journal

    Mia Carakovac, Jelena Jovanovic, Marko Kalanj, Nenad Rudic, Olivera Aleksic-Hil, Branko Aleksic, Itzel Bustos Villalobos, Hideki Kasuya, Norio Ozaki, Dusica Lecic-Tosevski, Milica Pejovic-Milovancevic

    SCIENTIFIC REPORTS   Vol. 6   page: 38222   2016.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Early detection of Autism Spectrum Disorder (ASD) has proven to be of high significance, however there is a limited availability of ASD screening tools in Serbian language. In this study we aim to translate, assess reliability and, in part, test the applicability of Modified Checklist for Autism in Toddlers, Revised, with Follow-Up (M-CHAT R/F) in Serbian Healthcare environment. We screened 128 children in three primary healthcare centres and 20 children in a tertiary psychiatric center, using M-CHAT R/F translated into Serbian language, between December 2014 and October 2015. At the end of the screening process 80% of participants in the risk group screened positive for ASD, while in the control group 4 (3.1%) participants screened positive, with a mean total scores of 8.25 and 0.66 respectively. The Cronbach's a coefficient was 0.91 and Guttman's.6 was 0.93. Test-retest reliability was deemed as acceptable, and no significant correlation was found between M-CHAT-R/F scores and Epworth Sleepiness Scale for children scores. The Serbian version of the M-CHAT-R/F has shown satisfactory reliability. We can therefore assert that it is a reliable tool for identifying ASD and it can be used in clinical practice to improve early detection, assessment and treatment.

    DOI: 10.1038/srep38222

    Web of Science

    Scopus

    PubMed

    researchmap

  100. Investigation of single-nucleotide variants in MBD5 associated with autism spectrum disorders and schizophrenia phenotypes Reviewed

    Kanako Ishizuka, Hiroki Kimura, Akira Yoshimi, Masahiro Banno, Itaru Kushima, Yota Uno, Takashi Okada, Daisuke Mori, Branko Aleksic, Norio Ozaki

    Nagoya Journal of Medical Science   Vol. 78 ( 4 ) page: 465 - 474   2016.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NAGOYA UNIV, SCH MED  

    MBD5 (Methyl-CpG-binding domain 5) is a critical gene for normal development. While deletion or duplication of MBD5 may contribute to a genetic predisposition to autism spectrum disorders (ASD), intellectual disability, or epilepsy, the impact of rare MBD5 single nucleotide variants (SNVs) on neurodevelopmental features, particularly features with late onset, has not been fully explored. In this study, we conducted exon-targeted resequencing of MBD5 with next-generation sequencing technology in 562 Japanese patients (192 with idiopathic ASD and 370 with schizophrenia (SCZ)) and detected 16 MBD5 SNVs with allele frequencies of &lt;= 1%. We then performed phenotype analyses with 12 novel variants of these 16 SNVs. SCZ patients with these variants exhibited mainly within normal development ranges until the first psychosis and ASD patients with SNVs did not precisely overlap with the core characteristics described in previous literature as being associated with MBD5 SNVs. Our results suggested that MBD5 variants might contribute to a broad spectrum of neurodevelopmental pathophysiology. Further research and assessment of clinical diagnostic screening are necessary for understanding the burden of rare MBD5 SNVs for these neurodevelopmental disorders.

    DOI: 10.18999/nagjms.78.4.465

    Web of Science

    researchmap

  101. Mutation screening of GRIN2B in schizophrenia and autism spectrum disorder in a Japanese population. Invited Reviewed

    Takasaki Y, Koide T, Wang C, Kimura H, Xing J, Kushima I, Ishizuka K, Mori D, Sekiguchi M, Ikeda M, Aizawa M, Tsurumaru N, Iwayama Y, Yoshimi A, Arioka Y, Yoshida M, Noma H, Oya-Ito T, Nakamura Y, Kunimoto S, Aleksic B, Uno Y, Okada T, Ujike H, Egawa J, Kuwabara H, Someya T, Yoshikawa T, Iwata N, Ozaki N

    Scientific reports   Vol. 6   page: 33311   2016.9

     More details

    Language:English   Publishing type:Research paper (bulletin of university, research institution)  

    DOI: 10.1038/srep33311

    PubMed

  102. Current viewpoints on DSM-5 in Japan. Invited Reviewed

    Kuroki T, Ishitobi M, Kamio Y, Sugihara G, Murai T, Motomura K, Ogasawara K, Kimura H, Aleksic B, Ozaki N, Nakao T, Yamada K, Yoshiuchi K, Kiriike N, Ishikawa T, Kubo C, Matsunaga C, Miyata H, Asada T, Kanba S

    Psychiatry and clinical neurosciences   Vol. 70 ( 9 ) page: 371-93   2016.9

     More details

    Language:English   Publishing type:Research paper (bulletin of university, research institution)  

    DOI: 10.1111/pcn.12421

    PubMed

  103. Identification of a rare variant in CHD8 that contributes to schizophrenia and autism spectrum disorder susceptibility. Invited Reviewed

    Kimura H, Wang C, Ishizuka K, Xing J, Takasaki Y, Kushima I, Aleksic B, Uno Y, Okada T, Ikeda M, Mori D, Inada T, Iwata N, Ozaki N

    Schizophrenia research     2016.8

     More details

    Language:English   Publishing type:Research paper (bulletin of university, research institution)  

    DOI: 10.1016/j.schres.2016.08.023

    PubMed

  104. Validation and factor analysis of mother-infant bonding questionnaire in pregnant and postpartum women in Japan. Invited Reviewed

    Ohara M, Okada T, Kubota C, Nakamura Y, Shiino T, Aleksic B, Morikawa M, Yamauchi A, Uno Y, Murase S, Goto S, Kanai A, Masuda T, Ozaki N

    BMC psychiatry   Vol. 16   page: 212   2016.7

     More details

    Language:English   Publishing type:Research paper (bulletin of university, research institution)  

    DOI: 10.1186/s12888-016-0933-3

    PubMed

  105. Resequencing and Association Analysis of Six PSD-95-Related Genes as Possible Susceptibility Genes for Schizophrenia and Autism Spectrum Disorders. Invited Reviewed

    Xing J, Kimura H, Wang C, Ishizuka K, Kushima I, Arioka Y, Yoshimi A, Nakamura Y, Shiino T, Oya-Ito T, Takasaki Y, Uno Y, Okada T, Iidaka T, Aleksic B, Mori D, Ozaki N

    Scientific reports   Vol. 6   page: 27491   2016.6

     More details

    Language:English   Publishing type:Research paper (bulletin of university, research institution)  

    DOI: 10.1038/srep27491

    PubMed

  106. Behavioral and neurochemical abnormalities in heterozygous Reelin Orleans mutant mouse model of schizophrenia Reviewed International journal

    Yamada Kiyofumi, Sobue Akira, Aoyama Yuki, Wei Shan, Nagai Taku, Aleksic Branko, Kushima Itaru, Ozaki Norio

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY   Vol. 19   page: 185 - 185   2016.6

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

  107. Investigation of the association of rare single nucleotide variants in methyl-CpG-binding domain protein 5 (MBD5) with phenotypes of autism spectrum disorders and schizophrenia. Reviewed International journal

    Ishizuka Kanako, Aleksic Branko, Chenyao Wang, Kimura Hiroki, Kushima Itaru, Okada Takashi, Ozaki Norio, Uno Yota

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY   Vol. 19   page: 172 - 173   2016.6

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

  108. Parental Origin of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia and Neurodevelopmental Disorders. Invited Reviewed

    PLoS genetics   Vol. 12 ( 5 ) page: e1005993   2016.5

     More details

    Language:English   Publishing type:Research paper (bulletin of university, research institution)  

    DOI: 10.1371/journal.pgen.1005993

    PubMed

  109. PM338. Investigation of the association of rare single nucleotide variants in methyl-CpG-binding domain protein 5 (MBD5) with phenotypes of autism spectrum disorders and schizophrenia. Reviewed International journal

    Ishizuka K, Aleksic B, Chenyao W, Kimura H, Kushima I, Okada T, Ozaki N, Uno Y

    The international journal of neuropsychopharmacology     2016.5

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/ijnp/pyw041.338

    researchmap

  110. Investigation of Rare Single-Nucleotide PCDH15 Variants in Schizophrenia and Autism Spectrum Disorders. Invited Reviewed

    Ishizuka K, Kimura H, Wang C, Xing J, Kushima I, Arioka Y, Oya-Ito T, Uno Y, Okada T, Mori D, Aleksic B, Ozaki N

    PloS one   Vol. 11 ( 4 ) page: e0153224   2016.4

     More details

    Language:English   Publishing type:Research paper (bulletin of university, research institution)  

    DOI: 10.1371/journal.pone.0153224

    PubMed

  111. Association of copy number polymorphisms at the promoter and translated region of COMT with Japanese patients with schizophrenia. Invited Reviewed

    Higashiyama R, Ohnuma T, Takebayashi Y, Hanzawa R, Shibata N, Yamamori H, Yasuda Y, Kushima I, Aleksic B, Kondo K, Ikeda M, Hashimoto R, Iwata N, Ozaki N, Arai H

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics   Vol. 171B ( 3 ) page: 447-57   2016.4

     More details

    Language:English   Publishing type:Research paper (bulletin of university, research institution)  

    DOI: 10.1002/ajmg.b.32426

    PubMed

  112. Association of Beck Depression Inventory score and Temperament and Character Inventory-125 in patients with eating disorders and severe malnutrition. Invited Reviewed

    Tanaka S, Yoshida K, Katayama H, Kohmura K, Kawano N, Imaeda M, Kato S, Ando M, Aleksic B, Nishioka K, Ozaki N

    Journal of eating disorders   Vol. 3   page: 36   2015.11

     More details

    Language:English   Publishing type:Research paper (bulletin of university, research institution)  

    DOI: 10.1186/s40337-015-0077-8

    PubMed

  113. Association study of BCL9 gene polymorphism rs583583 with schizophrenia and negative symptoms in Japanese population.

    Kimura H, Tanaka S, Kushima I, Koide T, Banno M, Kikuchi T, Nakamura Y, Shiino T, Yoshimi A, Oya-Ito T, Xing J, Wang C, Takasaki Y, Aleksic B, Okada T, Ikeda M, Inada T, Iidaka T, Iwata N, Ozaki N

    Scientific reports   Vol. 5   page: 15705   2015.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/srep15705

    PubMed

  114. White matter microstructure between the pre-SMA and the cingulum bundle is related to response conflict in healthy subjects. Invited Reviewed

    Yamamoto M, Kushima I, Kimura H, Hayashi A, Kawano N, Aleksic B, Iidaka T, Ozaki N

    Brain and behavior   Vol. 5 ( 10 ) page: e00375   2015.9

     More details

    Language:English   Publishing type:Research paper (bulletin of university, research institution)  

    DOI: 10.1002/brb3.375

    PubMed

  115. Glia-related genes and their contribution to schizophrenia.

    Wang C, Aleksic B, Ozaki N

    Psychiatry and clinical neurosciences   Vol. 69 ( 8 ) page: 448-61   2015.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/pcn.12290

    PubMed

  116. Deep sequencing and association analysis of schizophrenia candidate genes: Focus on glial assembly Reviewed International journal

    Aleksic Branko, Kimura Hiroki, Xing Jingrui, Wang Chenyao, Takasaki Yuto, Ishizuka Kanako, Mori Daisuke, Kushima Itaru, Oya Tomoko, Nakamura Yukako, Yoshimi Akira, Ozaki Norio

    JOURNAL OF PHARMACOLOGICAL SCIENCES   Vol. 128 ( 3 ) page: S42 - S42   2015.7

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

  117. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.

    Miyata A, Iwamoto K, Kawano N, Kohmura K, Yamamoto M, Aleksic B, Ebe K, Noda A, Noda Y, Iritani S, Ozaki N

    Psychopharmacology   Vol. 232 ( 12 ) page: 2127-37   2015.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00213-014-3843-4

    PubMed

  118. Relationship between social support during pregnancy and postpartum depressive state: a prospective cohort study.

    Morikawa M, Okada T, Ando M, Aleksic B, Kunimoto S, Nakamura Y, Kubota C, Uno Y, Tamaji A, Hayakawa N, Furumura K, Shiino T, Morita T, Ishikawa N, Ohoka H, Usui H, Banno N, Murase S, Goto S, Kanai A, Masuda T, Ozaki N

    Scientific reports   Vol. 5   page: 10520   2015.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/srep10520

    PubMed

  119. Early exposure to the combined measles-mumps-rubella vaccine and thimerosal-containing vaccines and risk of autism spectrum disorder.

    Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N

    Vaccine   Vol. 33 ( 21 ) page: 2511-6   2015.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.vaccine.2014.12.036

    PubMed

  120. Temperament and character profiles of patients with burning mouth syndrome.

    Tokura T, Kimura H, Ito M, Nagashima W, Sato N, Kimura Y, Arao M, Aleksic B, Yoshida K, Kurita K, Ozaki N

    Journal of psychosomatic research   Vol. 78 ( 5 ) page: 495-8   2015.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jpsychores.2015.02.006

    PubMed

  121. Identification of Rare, Single-Nucleotide Mutations in NDE1 and Their Contributions to Schizophrenia Susceptibility.

    Kimura H, Tsuboi D, Wang C, Kushima I, Koide T, Ikeda M, Iwayama Y, Toyota T, Yamamoto N, Kunimoto S, Nakamura Y, Yoshimi A, Banno M, Xing J, Takasaki Y, Yoshida M, Aleksic B, Uno Y, Okada T, Iidaka T, Inada T, Suzuki M, Ujike H, Kunugi H, Kato T, Yoshikawa T, Iwata N, Kaibuchi K, Ozaki N

    Schizophrenia bulletin   Vol. 41 ( 3 ) page: 744-53   2015.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1093/schbul/sbu147

    PubMed

  122. 【自閉症の生物学】自閉スペクトラム症の遺伝学研究の最近の進歩 Reviewed International journal

    木村 大樹, Aleksic Branko, 尾崎 紀夫

    細胞工学   Vol. 34 ( 5 ) page: 453 - 457   2015.4

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:(株)学研メディカル秀潤社  

    researchmap

  123. The Disrupted-in-Schizophrenia-1 Ser704Cys polymorphism and brain neurodevelopmental markers in schizophrenia and healthy subjects. Invited Reviewed

    Takahashi T, Nakamura M, Nakamura Y, Aleksic B, Kido M, Sasabayashi D, Takayanagi Y, Furuichi A, Nishikawa Y, Noguchi K, Ozaki N, Suzuki M

    Progress in neuro-psychopharmacology & biological psychiatry   Vol. 56   page: 11-7   2015.1

     More details

    Language:English  

    DOI: 10.1016/j.pnpbp.2014.07.005

    PubMed

  124. Resequencing and association analysis of PTPRA, a possible susceptibility gene for schizophrenia and autism spectrum disorders.

    Xing J, Wang C, Kimura H, Takasaki Y, Kunimoto S, Yoshimi A, Nakamura Y, Koide T, Banno M, Kushima I, Uno Y, Okada T, Aleksic B, Ikeda M, Iwata N, Ozaki N

    PloS one   Vol. 9 ( 11 ) page: e112531   2014.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1371/journal.pone.0112531

    PubMed

  125. Synaptic, transcriptional and chromatin genes disrupted in autism.

    Nature   Vol. 515 ( 7526 ) page: 209-15   2014.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/nature13772

    PubMed

  126. 【DSM-5】病因・病態研究から見たDSM-5 双極性障害とうつ病との分離の背景 Reviewed International journal

    木村 大樹, ブランコ・アレクシッチ, 尾崎 紀夫

    最新精神医学   Vol. 19 ( 5 ) page: 397 - 404   2014.9

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:(株)世論時報社  

    researchmap

  127. The polymorphism of YWHAE, a gene encoding 14-3-3epsilon, and brain morphology in schizophrenia: a voxel-based morphometric study.

    Kido M, Nakamura Y, Nemoto K, Takahashi T, Aleksic B, Furuichi A, Nakamura Y, Ikeda M, Noguchi K, Kaibuchi K, Iwata N, Ozaki N, Suzuki M

    PloS one   Vol. 9 ( 8 ) page: e103571   2014.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1371/journal.pone.0103571

    PubMed

  128. Factor structure of the Japanese version of the Edinburgh Postnatal Depression Scale in the postpartum period. Invited Reviewed

    Kubota C, Okada T, Aleksic B, Nakamura Y, Kunimoto S, Morikawa M, Shiino T, Tamaji A, Ohoka H, Banno N, Morita T, Murase S, Goto S, Kanai A, Masuda T, Ando M, Ozaki N

    PloS one   Vol. 9 ( 8 ) page: e103941   2014.8

     More details

    Language:English  

    DOI: 10.1371/journal.pone.0103941

    PubMed

  129. Summaries of oral sessions at the XXI World Congress of Psychiatric Genetics, Boston, Massachusetts, 17-21 October 2013: state of the field. Invited Reviewed

    Akpudo H, Aleksic B, Alkelai A, Burton C, Carrillo-Roa T, Chen DT, Cheng MC, Cocchi E, Davis LK, Giori IG, Hubbard LM, Merikangas A, Moily NS, Okewole A, Olfson E, Pappa I, Reitt M, Singh AB, Steinberg J, Strohmaier J, Ting TT, van Hulzen KJ, O'Shea A, DeLisi LE

    Psychiatric genetics   Vol. 24 ( 4 ) page: 125-50   2014.8

     More details

    Language:English  

    DOI: 10.1097/YPG.0000000000000043

    PubMed

  130. Effects of maternal depressive symptomatology during pregnancy and the postpartum period on infant-mother attachment. Invited Reviewed

    Ohoka H, Koide T, Goto S, Murase S, Kanai A, Masuda T, Aleksic B, Ishikawa N, Furumura K, Ozaki N

    Psychiatry and clinical neurosciences   Vol. 68 ( 8 ) page: 631-9   2014.8

     More details

    Language:English  

    DOI: 10.1111/pcn.12171

    PubMed

  131. Novel rare variants in F-box protein 45 (FBXO45) in schizophrenia. Invited Reviewed

    Wang C, Koide T, Kimura H, Kunimoto S, Yoshimi A, Nakamura Y, Kushima I, Banno M, Kawano N, Takasaki Y, Xing J, Noda Y, Mouri A, Aleksic B, Ikeda M, Okada T, Iidaka T, Inada T, Iwata N, Ozaki N

    Schizophrenia research   Vol. 157 ( 1-3 ) page: 149-56   2014.8

     More details

    Language:English  

    DOI: 10.1016/j.schres.2014.04.032

    PubMed

  132. Replication and cross-phenotype study based upon schizophrenia GWASs data in the Japanese population: support for association of MHC region with psychosis. Invited Reviewed

    Saito T, Kondo K, Iwayama Y, Shimasaki A, Aleksic B, Yamada K, Toyota T, Hattori E, Esaki K, Ujike H, Inada T, Kunugi H, Kato T, Yoshikawa T, Ozaki N, Ikeda M, Iwata N

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics   Vol. 165B ( 5 ) page: 421-7   2014.7

     More details

    Language:English  

    DOI: 10.1002/ajmg.b.32246

    PubMed

  133. Social insecurity in relation to orbitofrontal activity in patients with eating disorders: a near-infrared spectroscopy study. Invited Reviewed

    Katayama H, Kohmura K, Tanaka S, Imaeda M, Kawano N, Noda Y, Nishioka K, Ando M, Aleksic B, Iidaka T, Ozaki N

    BMC psychiatry   Vol. 14   page: 173   2014.6

     More details

    Language:English  

    DOI: 10.1186/1471-244X-14-173

    PubMed

  134. The polymorphism of YWHAE, a gene encoding 14-3-3epsilon, and orbitofrontal sulcogyral pattern in patients with schizophrenia and healthy subjects. Invited Reviewed

    Takahashi T, Nakamura Y, Nakamura Y, Aleksic B, Takayanagi Y, Furuichi A, Kido M, Nakamura M, Sasabayashi D, Ikeda M, Noguchi K, Kaibuchi K, Iwata N, Ozaki N, Suzuki M

    Progress in neuro-psychopharmacology & biological psychiatry   Vol. 51   page: 166-71   2014.6

     More details

    Language:English  

    DOI: 10.1016/j.pnpbp.2014.02.005

    PubMed

  135. Proteomic analysis of the lymphoblastoid cell line derived from Japanese schizophrenic patients Reviewed International journal

    Yoshimi A., Kunimoto S., Yamada S., Aleksic B., Hirakawa A., Nagai T., Ozaki N.

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY   Vol. 17   page: 119 - 119   2014.6

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

  136. Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer. Invited Reviewed

    Kasuya H, Kodera Y, Nakao A, Yamamura K, Gewen T, Zhiwen W, Hotta Y, Yamada S, Fujii T, Fukuda S, Tsurumaru N, Kuwahara T, Kikumori T, Koide Y, Fujimoto Y, Nakashima T, Hirooka Y, Shiku H, Tanaka M, Takesako K, Kondo T, Aleksic B, Kawashima H, Goto H, Nishiyama Y

    Hepato-gastroenterology   Vol. 61 ( 131 ) page: 599-605   2014.5

     More details

    Language:English  

    PubMed

  137. Preoperative level of depression is a predictor of postoperative levels of depression in patients with head and neck cancer. Invited Reviewed

    Adachi Y, Kimura H, Sato N, Nagashima W, Nakamura K, Aleksic B, Yoshida K, Fujimoto Y, Nakashima T, Ozaki N

    Japanese journal of clinical oncology   Vol. 44 ( 4 ) page: 311-7   2014.4

     More details

    Language:English  

    DOI: 10.1093/jjco/hyu002

    PubMed

  138. Copy-number variation in the pathogenesis of autism spectrum disorder. Invited Reviewed

    Shishido E, Aleksic B, Ozaki N

    Psychiatry and clinical neurosciences   Vol. 68 ( 2 ) page: 85-95   2014.2

     More details

    Language:English  

    DOI: 10.1111/pcn.12128

    PubMed

  139. Genetic association study between the detected risk variants based upon type II diabetes GWAS and psychotic disorders in the Japanese population. Invited Reviewed

    Kajio Y, Kondo K, Saito T, Iwayama Y, Aleksic B, Yamada K, Toyota T, Hattori E, Ujike H, Inada T, Kunugi H, Kato T, Yoshikawa T, Ozaki N, Ikeda M, Iwata N

    Journal of human genetics   Vol. 59 ( 1 ) page: 54-6   2014.1

     More details

    Language:English  

    DOI: 10.1038/jhg.2013.116

    PubMed

  140. Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia. Invited Reviewed

    Ikeda M, Okahisa Y, Aleksic B, Won M, Kondo N, Naruse N, Aoyama-Uehara K, Sora I, Iyo M, Hashimoto R, Kawamura Y, Nishida N, Miyagawa T, Takeda M, Sasaki T, Tokunaga K, Ozaki N, Ujike H, Iwata N

    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology   Vol. 38 ( 10 ) page: 1864-70   2013.9

     More details

    Language:English  

    DOI: 10.1038/npp.2013.94

    PubMed

  141. Genetic variants on 3q21 and in the Sp8 transcription factor gene (SP8) as susceptibility loci for psychotic disorders: a genetic association study. Invited Reviewed

    Kondo K, Ikeda M, Kajio Y, Saito T, Iwayama Y, Aleksic B, Yamada K, Toyota T, Hattori E, Ujike H, Inada T, Kunugi H, Kato T, Yoshikawa T, Ozaki N, Iwata N

    PloS one   Vol. 8 ( 8 ) page: e70964   2013.8

     More details

    Language:English  

    DOI: 10.1371/journal.pone.0070964

    PubMed

  142. Effectiveness of low-dose milnacipran for a patient suffering from pain disorder with delusional disorder (somatic type) in the orofacial region. Invited Reviewed

    Ukai K, Kimura H, Arao M, Aleksic B, Yamauchi A, Ishihara R, Iritani S, Kurita K, Ozaki N

    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society   Vol. 13 ( 2 ) page: 99-102   2013.6

     More details

    Language:English  

    DOI: 10.1111/j.1479-8301.2012.00430.x

    PubMed

  143. Genome-wide association study of cognitive decline in schizophrenia. Invited Reviewed

    Hashimoto R, Ikeda M, Ohi K, Yasuda Y, Yamamori H, Fukumoto M, Umeda-Yano S, Dickinson D, Aleksic B, Iwase M, Kazui H, Ozaki N, Weinberger DR, Iwata N, Takeda M

    The American journal of psychiatry   Vol. 170 ( 6 ) page: 683-4   2013.6

     More details

    Language:English  

    DOI: 10.1176/appi.ajp.2013.12091228

    PubMed

  144. Analysis of the VAV3 as candidate gene for schizophrenia: evidences from voxel-based morphometry and mutation screening. Invited Reviewed

    Aleksic B, Kushima I, Hashimoto R, Ohi K, Ikeda M, Yoshimi A, Nakamura Y, Ito Y, Okochi T, Fukuo Y, Yasuda Y, Fukumoto M, Yamamori H, Ujike H, Suzuki M, Inada T, Takeda M, Kaibuchi K, Iwata N, Ozaki N

    Schizophrenia bulletin   Vol. 39 ( 3 ) page: 720-8   2013.5

     More details

    Language:English  

    DOI: 10.1093/schbul/sbs038

    PubMed

  145. Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers. Invited Reviewed

    Sasada K, Iwamoto K, Kawano N, Kohmura K, Yamamoto M, Aleksic B, Ebe K, Noda Y, Ozaki N

    Human psychopharmacology   Vol. 28 ( 3 ) page: 281-6   2013.5

     More details

    Language:English  

    DOI: 10.1002/hup.2321

    PubMed

  146. Total palliative care for a patient with multiple cerebral infarctions that occurred repeatedly in association with gastric cancer (Trousseau's syndrome). Invited Reviewed

    Ukai K, Okajima A, Yamauchi A, Sasaki E, Yamaguchi Y, Kimura H, Aleksic B, Ozaki N

    Palliative & supportive care   Vol. 11 ( 2 ) page: 169-72   2013.4

     More details

    Language:English  

    DOI: 10.1017/S1478951512000624

    PubMed

  147. Effects of sedative antidepressants on prefrontal cortex activity during verbal fluency task in healthy subjects: a near-infrared spectroscopy study. Invited Reviewed

    Kohmura K, Iwamoto K, Aleksic B, Sasada K, Kawano N, Katayama H, Noda Y, Noda A, Iidaka T, Ozaki N

    Psychopharmacology   Vol. 226 ( 1 ) page: 75-81   2013.3

     More details

    Language:English  

    DOI: 10.1007/s00213-012-2885-8

    PubMed

  148. Definition and refinement of the 7q36.3 duplication region associated with schizophrenia. Invited Reviewed

    Aleksic B, Kushima I, Ohye T, Ikeda M, Kunimoto S, Nakamura Y, Yoshimi A, Koide T, Iritani S, Kurahashi H, Iwata N, Ozaki N

    Scientific reports   Vol. 3   page: 2587   2013

     More details

    Language:English  

    DOI: 10.1038/srep02587

    PubMed

  149. Effectiveness of duloxetine for the treatment of chronic nonorganic orofacial pain. Invited Reviewed

    Nagashima W, Kimura H, Ito M, Tokura T, Arao M, Aleksic B, Yoshida K, Kurita K, Ozaki N

    Clinical neuropharmacology   Vol. 35 ( 6 ) page: 273-7   2012.11

     More details

    Language:English  

    DOI: 10.1097/WNF.0b013e31827453fa

    PubMed

  150. An evaluation of polymorphisms in casein kinase 1 delta and epsilon genes in major psychiatric disorders. Invited Reviewed

    Matsunaga S, Ikeda M, Kishi T, Fukuo Y, Aleksic B, Yoshimura R, Okochi T, Yamanouchi Y, Kinoshita Y, Kawashima K, Umene-Nakano W, Inada T, Kunugi H, Kato T, Yoshikawa T, Ujike H, Nakamura J, Ozaki N, Kitajima T, Iwata N

    Neuroscience letters   Vol. 529 ( 1 ) page: 66-9   2012.10

     More details

    Language:English  

    DOI: 10.1016/j.neulet.2012.08.070

    PubMed

  151. What is a rational antidepressant treatment for major depression in patients with Parkinson's disease? Invited Reviewed

    Hagikura M, Iwamoto K, Aleksic B, Ozaki N

    Psychiatry and clinical neurosciences   Vol. 66 ( 5 ) page: 463   2012.8

     More details

    Language:English  

    DOI: 10.1111/j.1440-1819.2012.02362.x

    PubMed

  152. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia. Invited Reviewed

    Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N

    Vaccine   Vol. 30 ( 28 ) page: 4292-8   2012.6

     More details

    Language:English  

    DOI: 10.1016/j.vaccine.2012.01.093

    PubMed

  153. No associations found between the genes situated at 6p22.1, HIST1H2BJ, PRSS16, and PGBD1 in Japanese patients diagnosed with schizophrenia. Invited Reviewed

    Kitazawa M, Ohnuma T, Takebayashi Y, Shibata N, Baba H, Ohi K, Yasuda Y, Nakamura Y, Aleksic B, Yoshimi A, Okochi T, Ikeda M, Naitoh H, Hashimoto R, Iwata N, Ozaki N, Takeda M, Arai H

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics   Vol. 159B ( 4 ) page: 456-64   2012.6

     More details

    Language:English  

    DOI: 10.1002/ajmg.b.32049

    PubMed

  154. Slower adaptation to driving simulator and simulator sickness in older adults. Invited Reviewed

    Kawano N, Iwamoto K, Ebe K, Aleksic B, Noda A, Umegaki H, Kuzuya M, Iidaka T, Ozaki N

    Aging clinical and experimental research   Vol. 24 ( 3 ) page: 285-9   2012.6

     More details

    Language:English  

    PubMed

  155. Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility. Invited Reviewed

    Kushima I, Nakamura Y, Aleksic B, Ikeda M, Ito Y, Shiino T, Okochi T, Fukuo Y, Ujike H, Suzuki M, Inada T, Hashimoto R, Takeda M, Kaibuchi K, Iwata N, Ozaki N

    Schizophrenia bulletin   Vol. 38 ( 3 ) page: 552-60   2012.5

     More details

    Language:English  

    DOI: 10.1093/schbul/sbq118

    PubMed

  156. Differential effects of diazepam, tandospirone, and paroxetine on plasma brain-derived neurotrophic factor level under mental stress. Invited Reviewed

    Tamaji A, Iwamoto K, Kawamura Y, Takahashi M, Ebe K, Kawano N, Kunimoto S, Aleksic B, Noda Y, Ozaki N

    Human psychopharmacology   Vol. 27 ( 3 ) page: 329-33   2012.5

     More details

    Language:English  

    DOI: 10.1002/hup.2220

    PubMed

  157. Sexual dysfunction and hyperprolactinemia in Japanese schizophrenic patients taking antipsychotics. Invited Reviewed

    Kikuchi T, Iwamoto K, Sasada K, Aleksic B, Yoshida K, Ozaki N

    Progress in neuro-psychopharmacology & biological psychiatry   Vol. 37 ( 1 ) page: 26-32   2012.4

     More details

    Language:English  

    DOI: 10.1016/j.pnpbp.2011.11.016

    PubMed

  158. Prospective study on the association between harm avoidance and postpartum depressive state in a maternal cohort of Japanese women. Invited Reviewed

    Furumura K, Koide T, Okada T, Murase S, Aleksic B, Hayakawa N, Shiino T, Nakamura Y, Tamaji A, Ishikawa N, Ohoka H, Usui H, Banno N, Morita T, Goto S, Kanai A, Masuda T, Ozaki N

    PloS one   Vol. 7 ( 4 ) page: e34725   2012

     More details

    Language:English  

    DOI: 10.1371/journal.pone.0034725

    PubMed

  159. Wisconsin Card Sorting Test scores and clinical and sociodemographic correlates in Schizophrenia: multiple logistic regression analysis. Invited Reviewed

    Banno M, Koide T, Aleksic B, Okada T, Kikuchi T, Kohmura K, Adachi Y, Kawano N, Iidaka T, Ozaki N

    BMJ open   Vol. 2 ( 6 )   2012

     More details

    Language:English  

    DOI: 10.1136/bmjopen-2012-001340

    PubMed

  160. Evaluation of factors affecting continuous performance test identical pairs version score of schizophrenic patients in a Japanese clinical sample. Invited Reviewed

    Koide T, Aleksic B, Kikuchi T, Banno M, Kohmura K, Adachi Y, Kawano N, Iidaka T, Ozaki N

    Schizophrenia research and treatment   Vol. 2012   page: 970131   2012

     More details

    Language:English  

    DOI: 10.1155/2012/970131

    PubMed

  161. Common variants in MAGI2 gene are associated with increased risk for cognitive impairment in schizophrenic patients. Invited Reviewed

    Koide T, Banno M, Aleksic B, Yamashita S, Kikuchi T, Kohmura K, Adachi Y, Kawano N, Kushima I, Nakamura Y, Okada T, Ikeda M, Ohi K, Yasuda Y, Hashimoto R, Inada T, Ujike H, Iidaka T, Suzuki M, Takeda M, Iwata N, Ozaki N

    PloS one   Vol. 7 ( 5 ) page: e36836   2012

     More details

    Language:English  

    DOI: 10.1371/journal.pone.0036836

    PubMed

  162. Combination use of Beck Depression Inventory and two-question case-finding instrument as a screening tool for depression in the workplace. Invited Reviewed

    Adachi Y, Aleksic B, Nobata R, Suzuki T, Yoshida K, Ono Y, Ozaki N

    BMJ open   Vol. 2 ( 3 )   2012

     More details

    Language:English  

    DOI: 10.1136/bmjopen-2011-000596

    PubMed

  163. The postpartum depressive state in relation to perceived rearing: a prospective cohort study. Invited Reviewed

    Hayakawa N, Koide T, Okada T, Murase S, Aleksic B, Furumura K, Shiino T, Nakamura Y, Tamaji A, Ishikawa N, Ohoka H, Usui H, Banno N, Morita T, Goto S, Kanai A, Masuda T, Ozaki N

    PloS one   Vol. 7 ( 11 ) page: e50220   2012

     More details

    Language:English  

    DOI: 10.1371/journal.pone.0050220

    PubMed

  164. Combination use of two questionnaires for depression screening in the workplace (vol 2, e000596, 2012) Reviewed International journal

    Adachi Y., Branko A., Nobata R.

    BMJ OPEN   Vol. 2 ( 3 )   2012

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1136/bmjopen-2011-000596corr1

    Web of Science

  165. Loss of function studies in mice and genetic association link receptor protein tyrosine phosphatase α to schizophrenia. Invited Reviewed

      Vol. 70 ( 7 ) page: 626-35   2011.10

     More details

    Language:English  

    DOI: 10.1016/j.biopsych.2011.06.016

    PubMed

  166. Prospective study of maternal depressive symptomatology among Japanese women. Invited Reviewed

    Ishikawa N, Goto S, Murase S, Kanai A, Masuda T, Aleksic B, Usui H, Ozaki N

    Journal of psychosomatic research   Vol. 71 ( 4 ) page: 264-9   2011.10

     More details

    Language:English  

    DOI: 10.1016/j.jpsychores.2011.02.001

    PubMed

  167. Necessity for ethical consideration of research in the aftermath of disaster. Invited Reviewed

    Iijima Y, Aleksic B, Ozaki N

    Psychiatry and clinical neurosciences   Vol. 65 ( 5 ) page: 535-6   2011.8

     More details

    Language:English  

    DOI: 10.1111/j.1440-1819.2011.02238.x

    PubMed

  168. Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population. Invited Reviewed

    Yoshimura T, Usui H, Takahashi N, Yoshimi A, Saito S, Aleksic B, Ujike H, Inada T, Yamada M, Uchimura N, Iwata N, Sora I, Iyo M, Ozaki N

    Progress in neuro-psychopharmacology & biological psychiatry   Vol. 35 ( 5 ) page: 1268-72   2011.7

     More details

    Language:English  

    DOI: 10.1016/j.pnpbp.2011.04.003

    PubMed

  169. Reliability and validity of a new sexual function questionnaire (Nagoya Sexual Function Questionnaire) for schizophrenic patients taking antipsychotics. Invited Reviewed

    Kikuchi T, Iwamoto K, Sasada K, Aleksic B, Yoshida K, Ozaki N

    Human psychopharmacology   Vol. 26 ( 4-5 ) page: 300-6   2011.6

     More details

    Language:English  

    DOI: 10.1002/hup.1205

    PubMed

  170. Genome-wide association study of schizophrenia in a Japanese population. Invited Reviewed

    Ikeda M, Aleksic B, Kinoshita Y, Okochi T, Kawashima K, Kushima I, Ito Y, Nakamura Y, Kishi T, Okumura T, Fukuo Y, Williams HJ, Hamshere ML, Ivanov D, Inada T, Suzuki M, Hashimoto R, Ujike H, Takeda M, Craddock N, Kaibuchi K, Owen MJ, Ozaki N, O'Donovan MC, Iwata N

    Biological psychiatry   Vol. 69 ( 5 ) page: 472-8   2011.3

     More details

    Language:English  

    DOI: 10.1016/j.biopsych.2010.07.010

    PubMed

  171. Depression associated with alcohol intake and younger age in Japanese office workers: a case-control and a cohort study. Invited Reviewed

    Ogasawara K, Nakamura Y, Aleksic B, Yoshida K, Ando K, Iwata N, Kayukawa Y, Ozaki N

    Journal of affective disorders   Vol. 128 ( 1-2 ) page: 33-40   2011.1

     More details

    Language:English  

    DOI: 10.1016/j.jad.2010.06.015

    PubMed

  172. A case control association study and cognitive function analysis of neuropilin and tolloid-like 1 gene and schizophrenia in the Japanese population. Invited Reviewed

    Banno M, Koide T, Aleksic B, Yamada K, Kikuchi T, Kohmura K, Adachi Y, Kawano N, Kushima I, Ikeda M, Inada T, Yoshikawa T, Iwata N, Ozaki N

    PloS one   Vol. 6 ( 12 ) page: e28929   2011

     More details

    Language:English  

    DOI: 10.1371/journal.pone.0028929

    PubMed

  173. Gene-wide association study between the methylenetetrahydrofolate reductase gene (MTHFR) and schizophrenia in the Japanese population, with an updated meta-analysis on currently available data. Invited Reviewed

    Yoshimi A, Aleksic B, Kawamura Y, Takahashi N, Yamada S, Usui H, Saito S, Ito Y, Iwata N, Inada T, Noda Y, Yamada K, Ozaki N

    Schizophrenia research   Vol. 124 ( 1-3 ) page: 216-22   2010.12

     More details

    Language:English  

    DOI: 10.1016/j.schres.2010.07.011

    PubMed

  174. Influence of HTR2A polymorphisms and parental rearing on personality traits in healthy Japanese subjects. Invited Reviewed

    Nakamura Y, Ito Y, Aleksic B, Kushima I, Yasui-Furukori N, Inada T, Ono Y, Ozaki N

    Journal of human genetics   Vol. 55 ( 12 ) page: 838-41   2010.12

     More details

    Language:English  

    DOI: 10.1038/jhg.2010.110

    PubMed

  175. A two-stage case-control association study of the dihydropyrimidinase-like 2 gene (DPYSL2) with schizophrenia in Japanese subjects. Invited Reviewed

    Koide T, Aleksic B, Ito Y, Usui H, Yoshimi A, Inada T, Suzuki M, Hashimoto R, Takeda M, Iwata N, Ozaki N

    Journal of human genetics   Vol. 55 ( 7 ) page: 469-72   2010.7

     More details

    Language:English  

    DOI: 10.1038/jhg.2010.38

    PubMed

  176. Genetic association study of KREMEN1 and DKK1 and schizophrenia in a Japanese population. Invited Reviewed

    Aleksic B, Kushima I, Ito Y, Nakamura Y, Ujike H, Suzuki M, Inada T, Hashimoto R, Takeda M, Iwata N, Ozaki N

    Schizophrenia research   Vol. 118 ( 1-3 ) page: 113-7   2010.5

     More details

    Language:English  

    DOI: 10.1016/j.schres.2010.01.014

    PubMed

  177. Association study of bromodomain-containing 1 gene with schizophrenia in Japanese population. Invited Reviewed

    Kushima I, Aleksic B, Ikeda M, Yamanouchi Y, Kinoshita Y, Ito Y, Nakamura Y, Inada T, Iwata N, Ozaki N

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics   Vol. 153B ( 3 ) page: 786-91   2010.4

     More details

    Language:English  

    DOI: 10.1002/ajmg.b.31048

    PubMed

  178. Association study of ubiquitin-specific peptidase 46 (USP46) with bipolar disorder and schizophrenia in a Japanese population. Invited Reviewed

    Kushima I, Aleksic B, Ito Y, Nakamura Y, Nakamura K, Mori N, Kikuchi M, Inada T, Kunugi H, Nanko S, Kato T, Yoshikawa T, Ujike H, Suzuki M, Iwata N, Ozaki N

    Journal of human genetics   Vol. 55 ( 3 ) page: 133-6   2010.3

     More details

    Language:English  

    DOI: 10.1038/jhg.2009.139

    PubMed

  179. Copy number variation in schizophrenia in the Japanese population. Invited Reviewed

    Ikeda M, Aleksic B, Kirov G, Kinoshita Y, Yamanouchi Y, Kitajima T, Kawashima K, Okochi T, Kishi T, Zaharieva I, Owen MJ, O'Donovan MC, Ozaki N, Iwata N

    Biological psychiatry   Vol. 67 ( 3 ) page: 283-6   2010.2

     More details

    Language:English  

    DOI: 10.1016/j.biopsych.2009.08.034

    PubMed

  180. BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis. Invited Reviewed

    Kawashima K, Ikeda M, Kishi T, Kitajima T, Yamanouchi Y, Kinoshita Y, Okochi T, Aleksic B, Tomita M, Okada T, Kunugi H, Inada T, Ozaki N, Iwata N

    Schizophrenia research   Vol. 112 ( 1-3 ) page: 72-9   2009.7

     More details

    Language:English  

    DOI: 10.1016/j.schres.2009.03.040

    PubMed

  181. A genetic association study of the FXYD domain containing ion transport regulator 6 (FXYD6) gene, encoding phosphohippolin, in susceptibility to schizophrenia in a Japanese population. Invited Reviewed

    Ito Y, Nakamura Y, Takahashi N, Saito S, Aleksic B, Iwata N, Inada T, Ozaki N

    Neuroscience letters   Vol. 438 ( 1 ) page: 70-5   2008.6

     More details

    Language:English  

    DOI: 10.1016/j.neulet.2008.04.010

    PubMed

  182. Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample. Invited Reviewed

    Ikeda M, Takahashi N, Saito S, Aleksic B, Watanabe Y, Nunokawa A, Yamanouchi Y, Kitajima T, Kinoshita Y, Kishi T, Kawashima K, Hashimoto R, Ujike H, Inada T, Someya T, Takeda M, Ozaki N, Iwata N

    Schizophrenia research   Vol. 101 ( 1-3 ) page: 1-8   2008.4

     More details

    Language:English  

    DOI: 10.1016/j.schres.2008.01.010

    PubMed

  183. An association study of tachykinin receptor 3 gene with schizophrenia in the Japanese population. Invited Reviewed

    Saito S, Takahashi N, Maeno N, Ito Y, Aleksic B, Usui H, Iidaka T, Inada T, Ozaki N

    Neuroreport   Vol. 19 ( 4 ) page: 471-3   2008.3

     More details

    Language:English  

    DOI: 10.1097/WNR.0b013e3282f600b4

    PubMed

  184. An association study of tachykinin receptor 3 gene with schizophrenia in the Japanese population Reviewed International journal

    Saito Shinichi, Takahashi Nagahide, Maeno Nobuhisa, Ito Yoshihito, Aleksic Branko, Usui Hinako, Iidaka Tetsuya, Inada Toshiya, Ozaki Norio

    NEUROREPORT   Vol. 19 ( 4 ) page: 471 - 473   2008.3

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

  185. Genetic analysis of the gene coding for DARPP-32 (PPP1R1B) in Japanese patients with schizophrenia or bipolar disorder. Invited Reviewed

    Yoshimi A, Takahashi N, Saito S, Ito Y, Aleksic B, Usui H, Kawamura Y, Waki Y, Yoshikawa T, Kato T, Iwata N, Inada T, Noda Y, Ozaki N

    Schizophrenia research   Vol. 100 ( 1-3 ) page: 334-41   2008.3

     More details

    Language:English  

    DOI: 10.1016/j.schres.2007.10.028

    PubMed

  186. An association between serotonin receptor 3B gene (HTR3B) and treatment-resistant schizophrenia (TRS) in a Japanese population. Invited Reviewed

    Ji X, Takahashi N, Branko A, Ishihara R, Nagai T, Mouri A, Saito S, Maeno N, Inada T, Ozaki N

    Nagoya journal of medical science   Vol. 70 ( 1-2 ) page: 11-7   2008.3

     More details

    Language:English  

    PubMed

  187. Association analysis of MTHFR gene in schizophrenia Reviewed International journal

    Kawamura Y., Takahashi N., Saito S., Usui H., Yoshimi A., Ito Y., Branko A., Ishihara R., Yoshida K., Iidaka T., Inada T., Iwata N., Noda Y., Ozaki N.

    PSYCHIATRY AND CLINICAL NEUROSCIENCES   Vol. 62 ( 1 ) page: S4 - S5   2008.2

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

  188. No association between the oligodendrocyte-related gene PLP1 and schizophrenia in the Japanese population. Invited Reviewed

    Aleksic B, Ikeda M, Ishihara R, Saito S, Inada T, Iwata N, Ozaki N

    Journal of human genetics   Vol. 53 ( 9 ) page: 863-6   2008

     More details

    Language:English  

    DOI: 10.1007/s10038-008-0318-7

    PubMed

  189. Association Study of the Calcineurin A Gamma Subunit Gene (PPP3CC) and Methamphetamine-Use Disorder in a Japanese Population A Collaborative Study by the Japanese Genetics Initiative for Drug Abuse Reviewed International journal

    Kinoshita Y., Ikeda M., Ujike H., Kitajima T., Yamanouchi Y., Aleksic B., Kishi T., Kawashima K., Ohkouchi T., Ozaki N., Inada T., Harano M., Komiyama T., Hori T., Yamada M., Sekine Y., Iyo M., Sora I., Iwata N.

    DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES   Vol. 1139   page: 57 - 62   2008

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1196/annals.1432.021

    Web of Science

  190. Gap junction, bipolar disorder and schizophrenia: Genetic association study Reviewed International journal

    Aleksic Branko, Ikeda Masashi, Ishihara Ryoko, Takahashi Nagahide, Saito Sinichi, Matsumoto Atsushi, Inada Toshiya, Idaka Tetsuya, Iwata Nakao, Ozaki Norio

    NEUROSCIENCE RESEARCH   Vol. 61   page: S219 - S219   2008

     More details

    Publishing type:Research paper (scientific journal)  

    Web of Science

  191. Association of SOX10 with schizophrenia in the Japanese population. Invited Reviewed

    Maeno N, Takahashi N, Saito S, Ji X, Ishihara R, Aoyama N, Branko A, Miura H, Ikeda M, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Iwata N, Inada T, Ozaki N

    Psychiatric genetics   Vol. 17 ( 4 ) page: 227-31   2007.8

     More details

    Language:English  

    DOI: 10.1097/YPG.0b013e3280ae6cd8

    PubMed

  192. Association of SOX10 with schizophrenia in the Japanese population

    Maeno Nobuhisa, Takahashi Nagahide, Saito Shinichi, Ji Xiaofei, Ishihara Ryoko, Aoyama Nagisa, Branko Aleksic, Miura Hideki, Ikeda Masashi, Suzuki Tatsuyo, Kitajima Tsuyoshi, Yamanouchi Yoshio, Kinoshita Yoko, Iwata Nakao, Inada Toshiya, Ozaki Norio

    PSYCHIATRIC GENETICS   Vol. 17 ( 4 ) page: 227-231   2007.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  193. Association study between the transferrin gene and schizophrenia in the Japanese population. Invited Reviewed

    Maeno N, Takahashi N, Saito S, Ji X, Branko A, Ishihara R, Yoshida K, Inada T, Iidaka T, Ozaki N

    Neuroreport   Vol. 18 ( 5 ) page: 517-20   2007.3

     More details

    Language:English  

    DOI: 10.1097/WNR.0b013e3280586890

    PubMed

  194. Association study between the transferrin gene and schizophrenia in the Japanese population

    Maeno Nobuhisa, Takahashi Nagahide, Saito Shinichi, Ji Xiaofei, Branko Aleksic, Ishihara Ryoko, Yoshida Keizo, Inada Toshiya, Iidaka Tetsuya, Ozaki Norio

    NEUROREPORT   Vol. 18 ( 5 ) page: 517-520   2007.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Web of Science

  195. Gap junction coding genes and schizophrenia: a genetic association study. Invited Reviewed

    Aleksic B, Ishihara R, Takahashi N, Maeno N, Ji X, Saito S, Inada T, Ozaki N

    Journal of human genetics   Vol. 52 ( 6 ) page: 498-501   2007

     More details

    Language:English  

    DOI: 10.1007/s10038-007-0142-5

    PubMed

▼display all

Books 1

  1. Genetics in Pediatric Consultation-Liaison Psychiatry and Multidisciplinary Management of Complex Conditions

    ALEKSIC Branko( Role: Joint author)

    Springer  2018  ( ISBN:9783319894881

     More details

    Language:English Book type:Textbook, survey, introduction

    This ambitious resource presents an inventive approach to integrating pediatric and mental health care based in comprehensive, family-centered service delivery. Its framework adds a problem-solving focus to the core principles of pediatric consultation-liaison psychiatry, emphasizing young patients’ developmental, family, and social context.

    researchmap

Presentations 2

  1. Genome-wide association study of schizophrenia in a Japanese population

     More details

    Event date: 2010.10

    Language:English   Presentation type:Oral presentation (general)  

    Country:Japan  

  2. Overview of the single SNP analysis of Japanese genome wide association study of schizophrenia

    18th World Congress on Psychiatric Genetics 

     More details

    Event date: 2010.10

    Language:English   Presentation type:Poster presentation  

    B. Aleksic, M. Ikeda, Y. Kinoshita, T. Okochi, N. Craddock, K. Kaibuchi, M. Owen, N. Ozaki, M. O'Donovan, N. Iwata

KAKENHI (Grants-in-Aid for Scientific Research) 4

  1. NGS of multiple onset schizophrenia families

    Grant number:18K07554  2018.4 - 2021.3

      More details

    Authorship:Principal investigator 

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

  2. 次世代シーケンサーを用いた統合失調症多発家系の遺伝子解析と病因・病態解明

    2015.4 - 2018.3

    科学研究費補助金  基盤研究(C)

      More details

    Authorship:Principal investigator 

  3. Exome sequencing of schizophrenia using families with multiple affected members

    Grant number:15K09804  2015.4 - 2018.3

    Aleksic Branko

      More details

    Authorship:Principal investigator 

    Grant amount:\4810000 ( Direct Cost: \3700000 、 Indirect Cost:\1110000 )

    In this research we dissected genetic architecture of schizophrenia using families with multiple affected members. Until now most family based exome sequencing used trio based design and research was focused mainly on de novo variants (i.e. variants that are not present in parents but exist in affected children). In the current research besides de novo variants we focused on inherited variants. These are variants that are present in all affected member in one pedigree. In addition we investigated variants that are rare and of high impact (i.e. splice site mutation and/or nonsense variants), which may be family specific but exhibit incomplete penetrance (i.e. present in both affected and non affected members of the same family.

  4. 日本人における統合失調症のゲノムワイド関連研究およびそのフォローアップ

    2010.4 - 2012.3

    科学研究費補助金  若手研究(B)

      More details

    Authorship:Principal investigator 

 

Teaching Experience (On-campus) 7

  1. Tutor to postgraduate research students (Psychiatry)

    2013

  2. Tutor to G30 postgraduate research students (Med. School)

    2013

  3. English seminars for G30 graduate students at Med. School Modern biology (G30 undergraduates)

    2013

  4. PBL tutorial (Med. School)

    2013

  5. Lectures within Human biology course (Med. School)

    2013

  6. Lectures within Genetics/Oncology course (Med. School)

    2013

  7. Basic seminar A (Med. school)

    2013

▼display all